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ABSTRACT 
ATRIAL FIBRILLATION SYMPTOM CLUSTERS 
Megan M. Streur 
Barbara J. Riegel 
Background: Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. The 
majority of adults with AF are symptomatic, and symptoms are major determinants of quality-of-
life. We proposed a theoretical model of symptom perception that involves both symptom 
detection and symptom interpretation. In order to better understand AF symptom perception, the 
aim of this body of work was to identify AF-specific symptom clusters, characterize individuals 
within clusters based on sociodemographic and clinical variables, and determine whether 
symptom cluster membership was associated with healthcare utilization (AF-related emergency 
department visits and hospitalizations). 
Methods/Results: Data sets from the Standard versus Atrial Fibrillation spEcific managemenT 
strategY (SAFETY) Trial (n=355) and Vanderbilt Atrial Fibrillation Registry (VAFR, n=1,501) were 
used to conduct cross-sectional secondary data analyses of adults with clinically verified AF. 
Symptom clusters were identified using self-reported symptoms and two statistical approaches: 
hierarchical cluster analysis and latent class analysis. Regression analyses were performed with 
VAFR to determine associations with healthcare utilization. Three symptom clusters were found 
using cluster analysis and SAFETY participants, 2 symptom clusters using cluster analysis and 
VAFR participants, and 4 symptom clusters using latent class analysis and VAFR participants. 
Symptom cluster membership was associated with gender, age, AF type, BMI, heart failure, 
coronary artery disease, current use of anti-arrhythmic medication, and history of ablation. 
Although the clusters differed between studies, when the results from the different studies were 
compared the results were complimentary. The symptom clusters found with VAFR were 
associated with an increased rate of AF-related emergency department visits and 
hospitalizations, either when compared to all individuals without that specific cluster (hierarchical 
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cluster analysis), or when compared to an Asymptomatic cluster of patients (latent class 
analysis). 
Conclusions: Clinically meaningful symptom clusters were identified that were associated with 
increased rates of healthcare utilization. Both modifiable and non-modifiable sociodemographic 
and clinical characteristics are associated with cluster membership. 
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CHAPTER 1: INTRODUCTION 
Introduction to the Problem 
 Atrial fibrillation (AF) symptoms are intrusive, emotionally distressing, and functionally 
limiting, with a resultant negative impact on quality-of-life.1,2 Healthcare providers use the 
presence of symptoms to determine the appropriate treatment strategy (rate versus rhythm 
control) and to evaluate treatment effectiveness.3,4 While the majority of individuals with AF 
experience symptoms, the type and number of symptoms can vary significantly between 
individuals.4-7 Even among typically symptomatic individuals, the presence and type of symptoms 
can fluctuate from one episode of AF to the next.8,9 The most common symptoms of AF include 
palpitations, shortness of breath, chest pain, dizziness, and fatigue.5  
 Symptom perception involves both the detection of physical sensations and the 
interpretation of meaning.10-13 Symptom detection is the awareness of abnormal bodily 
sensations, while interpretation encompasses the cognitive and emotional meaning of the 
detected sensations.10-13 It is unclear whether the reported variation in AF symptom perception is 
the result of differences in detection, interpretation, or both. Multiplicative effects from co-
occurring detected symptoms likely impacts symptom interpretation, and as such would influence 
an individual’s response to symptoms.  
 The perception of isolated symptoms is likely distinct from that of interacting groups of 
symptoms.10,14 The Symptoms Experience Model10 delineates that individual symptoms, and the 
interactions between symptoms, influence the overall meaning of the symptom experience and 
influence a variety of health outcomes. The presence of multiple symptoms adds to the 
complexity of the symptom perception process. Symptom clusters are groups of symptoms that 
co-occur and are related to each other, either due to a shared underlying mechanism, a shared 
covariance, or through a unique effect on patient outcomes.14-16 Exploring AF symptom clusters 
will advance our understanding of the complex interactions and associations between AF 
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symptoms.14 While the frequency of individual AF symptoms have been described,5 this body of 
work is the first that examined symptom clusters among adults with AF.  
 It is evident that variability in AF symptom perception exists both between and within 
individuals. However, there remains a paucity of knowledge regarding the symptoms and 
symptom clusters perceived by individuals with AF. Research examining the presence of AF 
symptom clusters and the impact on outcomes is an important first step towards understanding 
the importance of AF symptom variability. This dissertation is the starting point of a research 
trajectory that explores AF symptoms and symptom variability. This study increases knowledge of 
detected symptoms and symptom clusters, and the role they play in healthcare utilization 
decisions, thereby generating hypotheses for future studies on AF symptom perception and self-
care.  
Background and Significance 
AF is an emerging cardiovascular epidemic. The current prevalence of AF in the United 
States (US) is nearly 3 million and is projected to rise to 8 million by the year 2050 due to the 
aging population and improved survival from cardiovascular disease.17 AF disproportionately 
impacts older adults, affecting only 0.1% of adults younger than 55 years, but 3.8% of adults 60 
years or older, and 9% of adults 80 years or older.18 The financial burden of AF is significant, with 
a direct cost of 7 billion dollars annually in the US, the majority of which is attributable to 
hospitalizations.19 The cost of AF-related hospitalizations is projected to increase 55% by 2020 as 
compared to 2010.20 Symptoms are a major predictor of hospitalization among adults with AF.21  
 A strong correlation exists between AF symptoms and profound quality-of-life 
impairments.22 Prior qualitative research suggests that impaired quality-of-life may be related to 
the unpredictable and functionally limiting nature of AF symptoms.2 Interestingly, objective 
measures of disease, such as ejection fraction, are poorly correlated with quality-of-life 
measures.23 Furthermore, compared to patients with a greater extent of structural heart disease, 
adults with symptomatic AF have similar, and sometimes worse, impairment of quality-of-life.1 
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Because symptoms affect approximately 70-90% of individuals with AF, symptom alleviation is a 
critical aspect of AF management.6,24 
 Symptomatic episodes of AF are erratic and can recur despite lifestyle modifications and 
medical interventions.4 Individuals with symptomatic AF often feel unprepared to manage the 
unpredictable and functionally limiting symptoms of AF.2 AF symptoms are typically managed 
with either a rate control or a rhythm control strategy; however both approaches can fail to fully 
eradicate the symptoms associated with AF.4  
 Complicating AF symptom management is the fact that symptoms may correlate poorly 
with objectively assessed arrhythmia episodes.8,9,25,26 Objective assessment with telemetry 
reveals that individuals with AF may experience symptoms with some episodes of AF, while other 
AF episodes do not result in symptoms.9 Similarly, some individuals may perceive a symptomatic 
episode of AF when in fact they are in sinus rhythm.8,26 For example, when a group of adults with 
symptomatic AF were monitored with continuous home electrocardiography, 42% of reported 
symptomatic AF episodes were actually sinus rhythm.8 Another study found that device-detected 
arrhythmia events accounted for only 8% of the unique variance in AF symptom scores.25 An 
individual patient’s ability to accurately perceive AF ranges from 0% to 100%.8 These findings 
highlight our limited understanding of AF symptoms and suggest that factors other than 
arrhythmia occurrence alone are involved in the perception of symptoms. An unexplored area of 
research that may influence whether a person interprets symptoms as being related to AF is the 
number, type, and co-occurrence of symptoms experienced.  
 Prior research suggests that a number of factors influence symptom perception, 
including: age,3,27 gender,5,24,27,28 negative emotions,25 personality,28 type of AF (i.e. paroxysmal 
versus permanent),5,6 and conditions such as myocardial infarction27 and heart failure.29 For 
instance, research suggests that women have more frequent and severe AF symptoms,24,28 
although not a greater number of symptoms.25 Advanced age has also been shown to reduce 
perception of AF symptoms,27 although evidence remains somewhat contradictory.25 
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 Understanding the multi-faceted nature of AF symptom perception is critical to the 
advancement and improvement of AF symptom management. Unfortunately, our ability to 
improve AF symptom management is hindered by limited knowledge of AF symptom perception. 
Symptom perception varies dramatically among individuals with AF, ranging from no symptoms to 
severe symptoms that markedly impair quality-of-life and functional status.24 To better understand 
symptom perception, we must first define two important concepts: symptoms and symptom 
clusters.  
Symptoms 
 Symptoms are subjective bodily sensations that individuals recognize within themselves 
and consider a departure from normal function.10,13,30 Innumerable somatic stimuli occur every 
day, only a fraction of which reach conscious awareness.13 Bodily sensations are a result of 
detected somatic stimuli, and bodily sensations are considered symptoms if an individual 
considers the sensation abnormal.13 Of note in this definition is that symptoms do not necessarily 
indicate an illness or disease, just the subjective evaluation of the sensation as abnormal. This 
aspect of the definition is important since subjective reports of AF symptoms do not always 
correlate well with objective measurement of heart rhythm.8,9,25,26 
Symptom Clusters 
 Groups of related symptoms, or symptom clusters, likely influence symptom perception in 
unique ways compared to isolated symptoms.15 For this study, symptom clusters are defined as 
two or more co-occurring and related symptoms, although some authors consider three 
symptoms the minimum requirement for a symptom cluster.15,31 Symptoms may be related for a 
variety of reasons, including a shared underlying mechanism, a shared covariance, or through a 
unique effect on patient outcomes.14-16,31  
 A wide range of methods are used to quantify symptom clusters, including correlation 
analysis, graphical modeling, path analysis, latent class analysis, structural equation modeling, 
factor analysis, and cluster analysis.14,32 Some of these methods rely on the assumption of 
underlying latent factors relating the symptoms within clusters, while others rely on either 
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correlation or measurements of dissimilarity (e.g. Euclidean distance) between symptoms.14,32 
Symptoms can be clustered by symptom variables or by individuals, resulting in either groups of 
symptoms or groups of individuals with similar symptom patterns.15 When clustering groups of 
symptoms, a certain degree of correlation between all concurrent symptoms is to be expected, 
but the correlation of symptoms within clusters should be greater than the correlation of 
symptoms across different clusters.31 Many of the quantitative methods used to identify symptom 
clusters require a degree of subjectivity in determining the presence and number of clusters, 
which may be considered a weakness of symptom cluster research in general.32 However, a 
critical component of symptom cluster research is evaluation of the theoretical and clinical 
meaningfulness of statistically identified symptom clusters, making subjective evaluation 
acceptable for this line of inquiry.31,32 
 Although it is unlikely that AF symptoms occur in isolation, the concept of symptom 
clusters has not previously been explored in AF patients. Symptom clusters warrant analysis 
among adults with AF because of the known impact symptom clusters have on patient outcomes 
in other cardiovascular diseases. For example, symptom clusters have been shown to influence 
mortality and event-free survival among individuals with acute coronary syndrome and heart 
failure.33,34 Specific symptom clusters may also have a unique effect on quality-of-life.35 Further, 
symptom clusters may result from a shared underlying mechanism,36,37 making symptom cluster 
analysis an appealing approach to the exploration of symptom variability among individuals with 
AF. This dissertation is an important contribution to AF symptom research because it examines 
both the presence of symptom clusters, and the consequence of identified clusters on patient 
reported outcomes. By increasing knowledge of AF symptoms and symptom clusters, this body of 
work will contribute to hypothesis generation and suggestions for potential areas of exploration in 
future AF symptom research.  
Theoretical Model 
 We define symptom perception as a process of detecting symptoms and interpreting 
symptom meaning.10-13 The process of symptom perception is influenced by a variety of factors 
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including prior experience, demographic, cultural, clinical, physiological and psychological 
characteristics.10 As previously noted, a number of factors have been identified that influence the 
perception of AF symptoms including age,27 gender,5,24,27,28 negative emotions,25 personality,28 
type of AF (i.e. paroxysmal versus permanent),5,6 baseline functional status,3 and comorbid 
cardiovascular conditions.27,29 The type, number, and frequency of symptoms detected influences 
the individual patient’s interpretation of the symptom(s) meaning, which results in several 
potential consequences. Some of the potential consequences of AF symptom perception include 
healthcare utilization for symptom management (emergency services, hospitalizations, clinic 
appointments), reduced quality of life, and impaired functional status. The complexity of symptom 
perception is illustrated in Figure 1.1, modified from the Symptoms Experience Model10 and the 
Symptom Interpretation Model.12  
  
Figure 1.1: Theoretical model. Symptom perception involves detection and interpretation. 
Detection is described in terms of presence and frequency. Interpretation is described in terms of 
symptom meaning. Groups of symptoms (i.e. clusters) result in collective meaning.  
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Symptom detection is defined as the awareness of abnormal bodily sensations.10-13 
Symptom detection can be described in terms of symptom presence and frequency.10 Other 
terms used in the literature to describe detected symptoms include intensity, quality, burden, 
severity, and distress;10,30,38 however these terms suggest a cognitive or emotional appraisal of 
the detected symptom and are therefore excluded from our definition of symptom detection. 
 Symptom interpretation is defined as the emotional and cognitive process whereby each 
individual symptom is assigned meaning, and co-occurring related symptoms (symptom clusters) 
have a collective meaning.10,12 The interpretation of symptom meaning encompasses both 
symptom attribution and the implications the symptom has for the person’s life. The interpretation 
of meaning is subjective, and may or may not result in the attribution of the detected symptom to 
the appropriate source. For example, a person experiencing fatigue related to AF may attribute 
the symptom to normal aging, rather than considering it a symptom of AF. Likewise, a person 
experiencing palpitations may attribute the symptom to AF, when in fact they are experiencing 
sinus tachycardia. Symptoms may have a variety of personal meanings or implications. For 
example, symptoms may impact daily activities, relationships, or an individual’s sense of 
mortality,10 each of which would have a unique meaning for the patient. Further, symptom 
clusters likely influence symptom meaning in unique ways due to the multiplicative effect of co-
occurring symptoms.10 In our model collective meaning represents the meaning that results from 
the occurrence of symptom clusters.  
The detection and interpretation of symptoms influences an individual’s response to the 
symptoms. Potential consequences of AF symptoms include healthcare utilization for symptom 
management (emergency services, hospitalizations, clinic appointments), reduced quality of life, 
and impaired functional status. If an individual interprets a symptom as life-threatening, it is likely 
they would seek immediate medical attention, whereas if they interpret a symptom as a normal 
result of aging, then they may not seek medical attention.  As a result, an individual’s ability to 
accurately attribute and interpret the meaning of a symptom will influence their response to the 
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symptom. In this manner, symptom perception plays an important role in self-care decisions (e.g. 
the decision to seek medical attention).  
Gaps in the Literature 
 This dissertation uses a theoretically based approach to examine gaps in the literature 
related to AF symptom perception. To our knowledge this body of work is the first to describe AF 
symptom clusters and to evaluate the impact of symptom clusters on healthcare utilization. This 
work uses cross-sectional secondary data analyses to answer new and meaningful research 
questions, reducing the burden of research participation by capitalizing on existing data. 
Identifying symptom clusters and determining their association with healthcare utilization has the 
potential to improve risk stratification for patients with AF, and will be beneficial for the future 
development of interventions aimed at improving symptom management and self-care for 
individuals with AF. 
Purpose and Specific Aims 
 The overarching purpose of this body of work was to better understand AF symptom 
perception by examining detected AF symptoms, identifying symptom clusters, and exploring the 
relationship between clusters and healthcare utilization. To achieve these aims we utilized two 
existing data sets from the Standard versus Atrial Fibrillation spEcific managemenT strategY 
(SAFETY) Trial39 and the Vanderbilt Atrial Fibrillation Registry (VAFR).40  
The first aim was to examine symptoms detected by adults with AF and identify symptom 
clusters. Self-reported survey data on symptom presence and frequency were used for the 
identification of symptom clusters. We used both data sets and two statistical approaches 
(hierarchical cluster analysis and latent class analysis) for the identification of symptom clusters 
(Table 1.1). To our knowledge, this body of work represents the only research to date that 
addresses AF-specific symptom clusters.  
The second aim was to characterize individuals within symptom clusters based on 
demographic and clinical characteristics. There is currently a paucity of knowledge regarding the 
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inter-individual variability in AF symptoms. By increasing our understanding of the differences in 
symptoms between individuals with specific characteristics, this aim improves our ability to design 
tailored interventions for AF symptom management and self-care.  
The third aim was to determine whether symptom cluster membership is associated with 
healthcare utilization (AF-related hospitalizations and emergency department visits). We 
hypothesized that distinct AF-specific symptom clusters could be identified that were associated 
with AF-related hospitalizations and ED utilization. For this aim we used regression analysis to 
determine whether individuals within identified cluster were more likely to be hospitalized or use 
the emergency department for AF. Self-reported AF-related hospitalizations and emergency 
department visits from VAFR40 were used to achieve this aim. Theoretically, both AF-related 
hospitalizations and emergency department utilization could be reduced via improved symptom 
management and self-care. Therefore, the results of this aim will be used to determine potential 
outcomes for future self-care interventions for individuals with AF.   
Table 1.1 Specific Aims with Corresponding Data-set(s) and Chapters 
Specific Aim Data-Set Chapter 
Aim 1: Examine symptoms detected by 
adults with AF and identify symptom 
clusters 
SAFETY and VAFR  II, III, IV 
Aim 2: Characterize individuals within 
symptom clusters based on 
demographic and clinical 
characteristics 
SAFETY and VAFR II, III, IV 
Aim 3: Determine whether symptom 
cluster membership is associated with 
healthcare utilization (AF-related 
hospitalizations and emergency 
department visits) 
VAFR III, IV 
Summary 
 This dissertation explores the poorly understood and under-researched topic of AF 
symptom perception. Specifically, this theoretically based body of work identifies AF-specific 
symptom clusters, characterizes individuals within symptom clusters, and determines the 
association between symptom clusters and AF-related healthcare utilization. The knowledge 
gained from this dissertation was used to develop future recommendations for research and 
clinical practice in relation to AF symptom management and self-care. 
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CHAPTER 2: SYMPTOM CLUSTERS IN ADULTS WITH CHRONIC ATRIAL FIBRILLATION  
(In Press: Journal of Cardiovascular Nursing) 
Authors: Megan Streur, Sarah J Ratcliffe, Jocasta Ball, Simon Stewart, Barbara Riegel 
Abstract 
Background: Symptom clusters have not previously been explored among individuals with atrial 
fibrillation of any type. Objective: The purpose of this study was to determine the number of 
symptom clusters present among adults with chronic atrial fibrillation and to explore 
sociodemographic and clinical factors potentially associated with cluster membership. Methods: 
This was a cross-sectional secondary data analysis of 335 Australian community-dwelling adults 
with chronic (recurrent paroxysmal, persistent, or permanent) atrial fibrillation. We used self-
reported symptoms and agglomerative hierarchical cluster analysis to determine the number and 
content of symptom clusters present. Results: There were slightly more male participants (52%) 
than female, with a mean age of 72 (±11.25) years. Three symptom clusters were evident, 
including a vagal cluster (nausea and diaphoresis), a tired cluster (fatigue/lethargy, weakness, 
syncope/dizziness, and dyspnea/breathlessness), and a heart cluster (chest pain/discomfort and 
palpitations/fluttering). We compared patient characteristics between those with all the symptoms 
in the cluster, those with some of the symptoms in the cluster, and those with none of the 
symptoms in the cluster. The only statistically significant differences were in age, gender, and the 
use of anti-arrhythmic medications for the heart cluster. Women were more likely to have the 
heart symptom cluster than men. Individuals with all of the symptoms in the heart cluster were 
younger (69.6 versus 73.7, p=0.029) than those with none of the symptoms in the heart cluster, 
and were more likely to be on anti-arrhythmic medications. Conclusion: Three unique atrial 
fibrillation symptom clusters were identified in this study population. 
Keywords: atrial fibrillation, adult, cardiovascular disease, symptom cluster 
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Introduction 
 Atrial fibrillation (AF) is the most common cardiac arrhythmia, with an estimated global 
prevalence of 2.8%.1 AF affects more than 3 million individuals in the United States (US) alone.2 
Emergency department visits and hospitalizations for AF are costly and rising both in the US and 
globally. In the US, emergency department visits for AF increased by 88% between 1993 and 
2004.3 Approximately 64% of those seen in US emergency departments for AF are subsequently 
hospitalized.3 The direct cost of AF in the US is nearly 7 billion dollars annually, which is primarily 
attributable to hospitalizations.4 Globally, the proportion of healthcare spending attributable to the 
direct costs of AF ranges from 0.28 to 1.01%.1 By 2020 the cost of AF-related hospitalizations is 
predicted to increase by 55% compared to 2010.5 Symptoms are a main predictor of 
hospitalizations among individuals with AF.6 
 Symptoms are an important but under-researched aspect of AF. A wide spectrum of 
symptom experiences occur among AF patients, with some experiencing multiple, severe 
symptoms and others experiencing no, few, or vague symptoms.7,8 The goals of AF management 
are to prevent severe complications associated with AF and reduce or eliminate symptoms. There 
are three primary strategies to achieve these goals: prevention of thromboembolism, heart rate 
control, and restoration of sinus rhythm.8 Preventing thromboembolism and rate-control are goals 
regardless of symptom status. AF symptoms, which negatively impact functional status and 
quality of life,9,10 are a primary consideration when determining whether to attempt restoration of 
sinus rhythm for longer-term management of recurrent paroxysmal or persistent AF.8 
Unfortunately, little is understood regarding AF symptom variability and the mechanisms of AF 
symptoms,11 which may hamper our ability to make effective treatment decisions.   
 While the frequency of individual AF symptoms has been described,7 it is likely that AF 
symptoms co-occur as symptom clusters; groups of two or more related and co-occurring 
symptoms.12,13 Symptom clusters occur as the result of a shared etiology, a shared covariance, or 
a shared effect on outcomes.12-15 Symptom clusters could help explain the variability of AF 
symptoms experienced and may be associated with treatment outcomes. Furthermore, AF-
17 
 
 
specific symptom clusters may be associated with underlying physiologic processes related to 
clinical variables, the sub-type of AF, or the etiology of AF. Understanding the physiology 
underlying symptom clusters may assist clinicians to better individualize treatment. If associations 
between symptom clusters and outcomes exist, providers could use symptom cluster assessment 
as a method of risk stratification. Thus, the purpose of this study was to determine the number of 
symptom clusters present among adults with chronic AF and to explore sociodemographic and 
clinical factors potentially associated with cluster membership.  
Methods 
 This study was a cross-sectional secondary data analysis of data from a randomized 
controlled pragmatic clinical trial conducted in Australia between 2010 and 2014; the Standard 
versus Atrial Fibrillation spEcific managemenT strategY (SAFETY) Trial.16 Applicable ethics board 
approvals were obtained as required for the original trial16 and through the University of 
Pennsylvania Institutional Review Board for this secondary data analysis. The methods and 
results of the trial have been reported previously.16,17 Methods are summarized briefly here: 
 A total of 335 individuals were included in the SAFETY Trial. Participants were eligible if 
they had a diagnosis of chronic AF, lived independently within the community following their index 
hospital admission (within a radius of 40km), and provided informed consent. Chronic AF was 
defined as recurrent paroxysmal, persistent, or permanent AF. Exclusion criteria included a 
primary diagnosis of valvular heart disease, a scheduled catheter ablation procedure, a pre-
existing diagnosis of heart failure (all patients were subject to echocardiography to exclude this 
diagnosis), transient AF (i.e. AF associated with acute myocardial infarction, pericarditis, recent 
cardiac surgery, sepsis, or excessive alcohol), or a terminal disorder or malignant disease that 
required palliative care.17 All participants in the original cohort were included in this cross-
sectional secondary data analysis.  
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Measurement of Variables 
Atrial Fibrillation Symptoms 
 Symptoms were measured using an AF profiling tool developed specifically for the 
SAFETY Trial. For this cluster analysis we used self-reported symptoms collected during the 
index hospitalization (Appendix 1). Each symptom was reported on a binary (yes/no) scale. 
Participants were instructed to report all symptoms previously or currently experienced in 
association with AF. Six common symptoms of AF were measured: dyspnea/breathlessness, 
syncope/dizziness, fatigue/lethargy, palpitations/fluttering, chest pain/discomfort, and weakness. 
Participants could report other symptoms via free-text response. Nausea and diaphoresis were 
commonly reported using the other option, and were therefore included in this analysis. 
Participants also reported if they did not experience symptoms when in AF, which was recorded 
as a binary yes/no response. 
Clinical and Demographic Variables 
 All participants were comprehensively profiled upon enrollment in the study. All clinical 
and demographic variables used for this analysis were obtained during the baseline assessment. 
Variables were collected by trained study personnel via medical record review and patient self-
report.  
Statistical Analysis 
 All data analysis was conducted in SAS version 9.4 (Cary, North Carolina). Descriptive 
statistics were used to describe the data. Symptom clusters were identified with agglomerative 
hierarchical cluster analysis, because of our goal to create mutually exclusive groups of 
symptoms.14,18,19 Cluster analysis maximizes both the homogeneity within clusters and the 
heterogeneity between clusters.18,19 We used Ward’s method with Euclidean distance as the 
dissimilarity measure.18,20 The ideal number of clusters was determined using a combination of 
dendrograms, pseudo F, and pseudo T.18,21 Additionally, we compared the results of the cluster 
analysis with exploratory factor analysis to validate our findings. 
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 After identifying symptom clusters, we compared characteristics of individuals with each 
cluster to those without the cluster in order to understand the potential factors associated with 
cluster membership. To do this, we divided participants into three groups for each symptom 
cluster: those with all the symptoms in the cluster, those with some of the symptoms in the cluster 
(one or more, but not all, of the symptoms), and those with none of the symptoms in the cluster. 
Next, we used Fisher’s exact test, chi-square test, and Kruskal-Wallis one-way analysis of 
variance to determine the statistical significance of 13 factors to determine if these factors were 
associated with symptom cluster membership. We used a broad range of demographic and 
clinical characteristics, specifically age, gender, ethnicity, body mass index (BMI), Charlson 
Comorbidity Index,22 cardiovascular comorbidities, and cardiac medications. We considered 
these factors as potentially associated with cluster membership based on the results of prior 
research (e.g. the influence of age and gender), due to similarity of symptom profiles with 
selected comorbidities,8,11 and because of our assumption that certain medications may 
contribute to certain symptoms (e.g. beta-blockers and fatigue). Statistical significance was 
determined using the predetermined value of p<0.05.  
Results 
Sample Characteristics 
 The mean age of participants was 72 (±11.25), with a range of 40 to 93 years (Table 2.1). 
Participants were predominantly European/Caucasian (96%), and there were slightly more male 
participants (52%) than female. The majority considered themselves symptomatic (83%), with 
only 17% (n=57) reporting themselves as asymptomatic. Dyspnea/breathlessness was the most 
common symptom, affecting 56% of participants despite the absence of underlying heart failure. 
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Table 2.1: Baseline Characteristics and Symptoms of the SAFETY Trial Cohort 
                                                                      All                                                    
(N=335) 
Female
(N=161, 
48%) 
Male
(N=174, 
52%) 
Sociodemographic Profile 
 
  
Age (years)# 72 (±11.3) 74 (±10.3) 69 (±11.6) 
Ethnicity 
 
  
     European/Caucasian 323 (96.4%) 156 (96.9%)  167 (96.0%) 
     Aboriginal/Torres Strait Islander 4 (1.2%) 1 (0.6%)  3 (1.7%) 
     Asian 5 (1.5%) 3 (1.9%) 2 (1.2%) 
     Middle Eastern 3 (0.9%) 1 (0.6%) 2 (1.2%) 
Living Alone# 132 (39.4%) 82 (50.9%) 50 (28.7%) 
Clinical Profile 
 
  
AF Sub-Type    
     Recurrent Paroxysmal 9 (2.7%) 4 (2.5%) 5 (2.9%) 
     Persistent 293 (87.5%) 140 (87.0%) 153 (87.9%) 
     Permanent 33 (9.9%) 17 (10.6%) 16 (9.2%) 
Body Mass Index* 29.6 (±6.7) 30.5 (±7.9) 28.8 (±5.3) 
Charlson Comorbidity Index 4.9 (±2.6) 5.1 (±2.4) 4.7 (±2.7) 
Hypertension 240 (71.6%) 123 (76.4%) 117 (67.2%) 
Coronary Artery Disease* 112 (33.4%) 40 (24.8%) 72 (41.4%) 
Valve disease 12 (3.6%) 7 (4.4%) 5 (2.9%) 
History of Cardiac Revascularization Surgery# 68 (20.3%) 18 (11.2%) 50 (28.7%) 
Beta Blocker 165 (49.3%) 77 (47.8%) 88 (50.6%) 
Calcium Channel Blocker 74 (22.1%) 39 (24.2%) 35 (20.1%) 
Digoxin 117 (34.9%) 64 (39.8%) 53 (30.5%) 
Anti-Arrhythmic 101 (30.2%) 51 (31.7%) 50 (28.7%) 
Symptom Profile 
 
  
Asymptomatic (self-reported) 57 (17.0%) 21 (13.0%) 36 (20.7%) 
Dyspnea/Breathlessness 186 (55.5%) 93 (57.8%) 93 (53.5%) 
Fatigue/Lethargy* 168 (50.2%) 91 (56.5%) 77 (44.3%) 
Palpitations/Fluttering# 169 (50.5%) 102 (63.4%) 67 (38.5%) 
Weakness* 122 (36.4%) 70 (43.5%) 52 (29.9%) 
Chest Pain/Discomfort 136 (40.6%) 70 (43.5%) 66 (37.9%) 
Syncope/Dizziness 119 (35.5%) 65 (40.4%) 54 (31.0%) 
Nausea 21 (6.3%) 12 (7.5%) 9 (5.2%) 
Diaphoresis 15 (4.5%) 8 (5.0%) 7 (4.0%) 
Data are mean (± standard deviation) or number of patients (%). Characteristics that were 
significantly different between females and males are marked with an asterisk (*) for p<0.05, and 
with a pound sign (#) for p<0.001 
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Symptom Clusters 
 The dendrogram, pseudo-F and pseudo-T indicated that a three cluster solution was the 
optimal solution (Figure 2.1). We labeled the symptom clusters the vagal cluster (nausea and 
diaphoresis), tired cluster (fatigue/lethargy, weakness, syncope/dizziness, and 
dyspnea/breathlessness), and heart cluster (chest pain/discomfort and palpitations/fluttering). 
Both vagal cluster symptoms occurred in only 3 participants. The heart cluster was the most 
common, with all symptoms occurring in 26% (n=88) of participants. All tired cluster symptoms 
were present in 14% (n=47) of participants (Table 2.2). Over half with the tired cluster (n=24) also 
experienced the heart cluster (Table 2.3). 
 
 
 
 
 
 
Figure 2.1: Dendrogram of atrial fibrillation symptom clusters. All symptoms were self-reported at 
baseline  
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Table 2.2: Symptom Cluster Membership 
Cluster Membership 
 
Vagal Cluster (diaphoresis and nausea) N (%) 
     None of the symptoms 302 (90%) 
     Some of the symptoms 30 (9%) 
     All of the symptoms 3 (1%) 
Tired Cluster (weakness, fatigue, syncope/dizziness, 
dyspnea) 
 
     None of the symptoms 95 (28%) 
     Some of the symptoms 193 (58%) 
     All of the symptoms 47 (14%) 
Heart Cluster (chest pain and palpitations) 
 
     None of the symptoms 118 (35%) 
     Some of the symptoms 129 (39%) 
     All of the symptoms 88 (26%) 
 
Table 2.3: Cluster Co-occurrence within the SAFETY Trial Cohort 
Cluster Combinations 
 
Vagal Heart Tired 
Vagal 3 (0.9%) 2 (0.6%) 2 (0.6%) 
Heart 
 
88 (26%) 24 (7%) 
Tired 
  
47 (14%) 
 
Characteristics of Symptom Cluster Groups 
 There were no statistically significant differences in patient characteristics for the vagal or 
tired cluster. In the heart cluster, statistically significant differences were found in age, gender, AF 
sub-type, and use of anti-arrhythmic medications (Table 2.4). The mean age progressively 
declined for individuals with none (73.7 years, n=118) versus some (71 years, n=129) versus all 
(69.6 years, n=88) of the heart cluster symptoms. Participants with all the heart cluster symptoms 
were 4 years younger on average than individuals with none of the heart cluster symptoms (69.6 
versus 73.7 years, p=0.029). Women were significantly more likely to have the heart cluster than 
men (p=0.0015), with 20% of men (n=35) and 33% of women (n=53) having both of the heart 
cluster symptoms. Heart cluster membership varied by AF sub-type (p=0.042). Among 
participants with permanent AF, 55% had none, 30% had some, and 15% had all of the heart 
cluster symptoms. In contrast, 27% of participants with persistent and 33% with paroxysmal AF 
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had all of the heart cluster symptoms. In comparison, 18% of individuals with permanent AF had 
all the tired cluster symptoms, compared to 14% with persistent and 11% with paroxysmal AF, 
although not statistically significant. Participants with the heart cluster were more likely to take 
anti-arrhythmic medication as part of rhythm-control therapy than individuals without the heart 
cluster (p=0.002). Among participants with both heart cluster symptoms, 40% were on anti-
arrhythmics, compared to 34% for participants with one of the heart symptoms and 19% for 
participants with none of the heart symptoms. Comparatively, only 26% of participants with all the 
tired cluster symptoms were on anti-arrhythmics. Interestingly, we did not find a statistically 
significant relationship between the tired cluster and use of rate-control medications, even though 
rate-control medications have side-effect profiles similar to tired cluster symptoms. 
Table 2.4: Comparison of Heart Cluster Groups 
Characteristic None of the 
symptoms 
N=118  
Some of the 
symptoms 
N=129  
All of the 
symptoms 
N=88   
p-value 
Gender    0.002 
     Male (%) 76 (64.4%) 63 (48.8%) 35 (39.8%)  
     Female (%) 42 (35.6%) 66 (51.2%) 53 (60.2%)  
Age (years) 73.7 (±10.7) 71 (±11.6) 69.6 (±11.1) 0.029 
European/Caucasian Ethnicity (%) 115 (97.5%) 124 (96.1%) 84 (95.5%) 0.759 
AF Sub-Type    0.042 
     Recurrent Paroxysmal 5 (4.2%) 1 (0.8%) 3 (3.4%)  
     Persistent 95 (80.5%) 118 (91.5%) 80 (90.9%)  
     Permanent 18 (15.3%) 10 (7.8%) 5 (5.7%)  
Body Mass Index 29.9 (±7.6) 29.9 (±6.5) 28.8 (±5.4) 0.710 
Charlson Comorbidity Index 5.2 (±2.4) 4.8 (±2.6) 4.5 (±2.6) 0.108 
Hypertension (%) 87 (73.7%) 95 (73.6%) 58 (65.9%) 0.381 
Coronary Artery Disease (%) 49 (41.5%) 37 (28.7%) 26 (29.6%) 0.068 
Valve Disease (%) 6 (5.1%) 6 (4.7%) 0 (0%) 0.079 
Cardiac Surgery (%) 26 (22%) 23 (17.8%) 19 (21.6%) 0.672 
Beta Blocker (%) 66 (55.9%) 57 (44.2%) 42 (47.7%) 0.173 
Calcium Channel Blocker (%) 31 (26.3%) 26 (20.2%) 17 (19.3%) 0.392 
Digoxin (%) 37 (31.4%) 49 (38%) 31 (35.2%) 0.550 
Anti-Arrhythmic (%) 22 (18.6%) 44 (34.1%) 35 (39.8%) 0.002 
Statistically significant differences (p<0.05) are shown in bold. Data are mean (± standard 
deviation) or number of patients (%). 
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Discussion 
 This is the first study to establish the presence of AF symptom clusters in individuals with 
chronic forms of AF. We identified three distinct clusters; a vagal cluster (nausea and 
diaphoresis), tired cluster (fatigue, weakness, syncope/dizziness, and dyspnea), and heart cluster 
(palpitations and chest pain). These clusters are unique compared to symptom clusters identified 
among other cardiovascular patient populations (Table 2.5).23-25 The AF cluster that shares the 
most similarities with other cardiovascular clusters is the tired cluster, which shares some 
symptoms with heart failure physical symptom clusters. However, it is important to note that 
patients with heart failure were specifically excluded from this study cohort. Further, the AF tired 
cluster is unique because dizziness/syncope is included in our cluster. AF patients may have 
disease-specific mechanisms for dizziness/syncope, such as tachycardia, bradycardia or post-
conversion pause, which cause this symptom to cluster with fatigue, weakness, and dyspnea. 
Alternately, these symptoms are potentially pharmacologically based given the fine line between 
benefit and risk of adverse events in those being treated for AF.17 
Table 2.5: Cardiovascular Symptom Clusters 
 Symptom Cluster 
Acute Coronary 
Syndrome (ACS) 
1 
Classic ACS 
Cluster 
(chest pain) 
Pain Cluster 
(arm, back, 
shoulder, neck, 
throat, and jaw 
pain) 
Stress Cluster 
(shortness of 
breath, 
sweating, 
nausea, 
indigestion, 
dread, and 
anxiety) 
Diffuse Cluster 
(multiple 
symptoms 
present but with 
low 
representation 
of any particular 
symptom) 
Heart Failure2 Physical Cluster  
(dyspnea, fatigue/increase need to 
rest, fatigue/low energy, and sleep 
disturbances) 
Emotional/Cognitive Cluster 
(worrying, feeling depressed, and 
cognitive problems) 
Heart Failure3 Physical Capacity Cluster  
(dyspnea, difficulty walking or 
climbing, fatigue/increased need 
to rest, fatigue/low energy, and 
sleep difficulties) 
Emotional/Cognitive Cluster 
(worrying, feeling depressed, and 
cognitive problems) 
 
 The vagal cluster was quite rare (n=3) in our sample. However, the fact that symptoms 
associated with vasovagal response cluster together is interesting due to the well-recognized 
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occurrence of vagally-mediated AF.8,26. It is interesting to note that syncope/dizziness were 
measured as a single item in this study and clustered with the tired symptoms, rather than the 
vagal cluster. Future studies of AF symptom clusters should measure dizziness and syncope as 
distinct symptoms to determine whether one or the other may cluster differently if measured 
independently. 
 The tired cluster might be considered vague or non-specific11 and therefore not easily 
attributable to AF. However, dyspnea was the most frequently reported AF symptom in our 
sample (56%), followed closely by fatigue (50%), which occurred at the same frequency as 
palpitations (50%). These findings are in contrast to the large study by Levy et al.7 which found 
palpitations were the most common symptom of AF (54%), followed by dyspnea (44%) and 
fatigue (14%). The Levy7 study examined outpatients whereas our symptom data are from index 
hospital admissions, which may explain the difference in reported symptoms. AF results in loss of 
atrio-ventricular synchrony and often in tachycardia and/or bradycardia, which can adversely 
affect hemodynamic status through impaired diastolic filling and impaired left ventricular systolic 
function.11 Hemodynamic changes associated with AF are a plausible mechanism for the 
clustering of fatigue, weakness, dyspnea, and syncope/dizziness. 
 The heart cluster consists of the symptoms that may be the most readily attributed to AF, 
palpitations and chest pain. Certain individuals may be more prone to perceive sensations in the 
chest due to differences in afferent neural stimulation or central nervous system functioning.11,27 A 
study of heart transplant patients showed that despite cardiac denervation one-third of 
participants could still perceive their heartbeat, suggesting the perception of palpitations is 
unrelated to cardiac mechanoreceptors.28 Similarly, chest pain often occurs during AF despite the 
absence of acute coronary syndrome.29 Numerous studies reveal that neuropsychiatric variables 
influence the perception of AF symptoms,30-32 and palpitations in particular.33,34 Taken together, 
these findings support the idea that a mechanism outside the myocardium is responsible for the 
heart cluster symptoms. Further research is needed to elucidate the precise mechanisms of these 
26 
 
 
symptoms. Interestingly, the heart cluster was the only cluster with significant differences in 
patient characteristics between those with versus without the cluster.  
 Our results indicate that membership in the heart symptom cluster is associated with 
younger age, female gender, AF sub-type, and anti-arrhythmic use. Gender-based differences in 
the SAFETY cohort have been described previously: women in the cohort were older, more likely 
to experience symptomatic AF (especially fatigue, palpitations, and weakness), and presented 
with a unique clinical profile characterized by higher BMI, less coronary artery 
disease/revascularization, and more depression.35 Our study furthers these findings by revealing 
that symptom cluster membership also varies by gender. Previous reports indicate younger age 
and female gender are associated with an increased frequency and severity AF symptoms.31,36 
However, Sears et al.32 found that age and gender were not significantly associated with the 
number of AF symptoms reported. Our results indicate that age and gender are indeed non-
modifiable characteristics that influence certain aspects of symptom perception, specifically 
symptom clustering. While age and gender may not influence the number of symptoms reported, 
these characteristics do influence other aspects of symptom perception such as the type of 
symptoms experienced, and their perceived frequency and severity.  
 Gender differences in the SAFETY Trial may have contributed to the greater number of 
women who experienced the heart cluster. Depression was more common in women (p=0.017)35 
and may be an important factor effecting symptom perception. Higher levels of negative emotions 
are associated with a greater number of AF symptoms, influencing the number of symptoms 
experienced more than objectively measured episodes of AF.32 Similarly, increased severity of 
depression and anxiety are associated with increased AF symptom severity (p<0.001).31 
Palpitations were significantly more common among the women in our study, and are known to 
be influenced by neuropsychiatric variables.34 It is plausible that differences in neuropsychiatric 
variables influenced the number of men versus women that experienced the heart cluster. BMI 
also varied by gender in our study. Elevated BMI is a well-documented risk factor for AF 
development.37,38 It is possible that BMI may also influence heart cluster membership via altered 
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cardiac interoception,39 or as the result of perceived differences in symptom burden and 
severity.40  
 Heart cluster membership varied based on sub-type of AF. The results are difficult to 
interpret for participants with paroxysmal AF due to small numbers (n=9). However, our results 
indicate that permanent AF has a unique symptom presentation. Individuals with permanent AF 
were least likely to have all of the symptoms in the heart cluster. In contrast, these individuals 
were most likely to have all the tired cluster symptoms. These differences in symptom profile are 
important factors to consider in terms of clinical decision making related to symptom-
management. Unfortunately, symptom-management options are limited for individuals with 
permanent AF: Guidelines recommend against rhythm-control, and therefore symptoms are 
primarily managed through rate-control.8 Alternative therapies, such as yoga and biofeedback, 
can reduce AF symptoms and may be the most beneficial in individuals with permanent AF, but 
these methods are understudied in this population.41,42 
It is possible the large proportion of participants in the SAFETY cohort with persistent AF 
(87.5%) influenced the association between the heart cluster and anti-arrhythmic medication. 
However, the proportion of individuals with persistent AF was high both among individuals with all 
the heart cluster symptoms (90.9%) and all the tired cluster symptoms (85.1%), yet a statistically 
significance association with anti-arrhythmics was only found in the heart cluster. Another 
possible explanation is that patients and/or providers are more likely to consider palpitations and 
chest pain as symptoms of AF, or as more severe symptoms of AF, compared to the vague 
symptoms in the tired cluster, subsequently resulting in selection of a rhythm-control strategy. In 
fact, prior research indicates patients often erroneously attribute AF symptoms such as dyspnea 
and fatigue to ageing, deconditioning, or poor sleep, and that these erroneous attributions result 
in treatment-seeking delay prior to AF diagnosis.43-45 Further research is warranted to explore 
whether symptom attribution influences treatment decisions post-diagnosis among individuals 
with chronic forms of AF.   
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Limitations 
 This study has several limitations. First, we used symptom data collected with a survey 
that was not validated psychometrically, which could influence the cluster solution. Second, high 
levels of cognitive impairment (approximately two-thirds of participants) have been reported for 
this cohort, which likely influenced the ability of participants to recall and accurately report 
symptoms.46 However, the SAFETY cohort typifies patients with AF (minus individuals with 
concurrent heart failure), so we consider this an acceptable limitation for this study. Third, our 
findings are based on self-reported symptoms which were not correlated objectively with heart 
rhythm monitoring. Fourth, the symptoms reported in this study may not represent all possible 
symptoms of AF (e.g. emotional and cognitive symptoms),47,48 and as a result important clusters 
or components of clusters may be missing from this report. While we recognize the limitations of 
our study, we consider this work an important first step towards understanding symptom clusters 
and factors associated with cluster membership among adults with chronic AF.  
Conclusions 
 We identified three symptom clusters among adults with chronic AF, demonstrating that 
AF symptoms do not always occur in isolation. Cluster membership is associated with two non-
modifiable patient characteristics; age and gender. We also demonstrated that the combination of 
chest pain and palpitations is more likely to be associated with clinical factors including AF sub-
type and the use of anti-arrhythmic medications. Additional studies are warranted to replicate 
these findings and explore the impact of symptom clusters on patient treatment and outcomes.  
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Appendix 1: Profiling tool developed to assess AF symptoms in SAFETY Trial 
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CHAPTER 3: SYMPTOM CLUSTERS INCREASE RATE OF HOSPITALIZATIONS AND 
EMERGENCY DEPARTMENT VISITS IN ADULTS WITH ATRIAL FIBRILLATION 
Abstract 
Background: Symptom clusters among adults with atrial fibrillation have previously been 
identified but not verified with follow-up studies. No study to date has examined the relationship 
between symptom clusters and outcomes in adults with atrial fibrillation. Objective: The purpose 
of this study was to identify AF-specific symptom clusters, characterize individuals within each 
cluster, and determine whether symptom cluster membership is associated with AF-related 
hospitalizations and ED visits. Methods: This was a secondary data analysis of the 1,501 adults 
from the Vanderbilt Atrial Fibrillation Registry with clinically verified paroxysmal, persistent, or 
permanent atrial fibrillation. Self-reported symptoms were used to determine symptom clusters 
with hierarchical cluster analysis (Ward’s method). We used dendrograms, pseudo F, and pseudo 
T to determine the ideal number of clusters. Next, we then used regression analyses to examine 
the association between cluster membership and healthcare utilization. Results: Males 
predominated (67%) and the average age was 58.4 years. Two symptom clusters were identified, 
an At Rest cluster (3.7%, n=56, fatigue at rest, shortness of breath at rest, chest pain, and 
dizziness) and With Activity cluster (32.7%, n=491, shortness of breath with activity and exercise 
intolerance). Experiencing all the symptoms in the At Rest cluster resulted in nearly triple the rate 
of ED utilization (incident rate ratio 2.8, p<0.0001) and nearly twice the rate of hospitalizations 
(incident rate ratio 1.9, p<0.0001) compared to individuals with none of the At Rest symptoms. 
Conclusion: The At Rest symptom cluster is associated with significant increases in emergency 
department visits and hospitalizations. 
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Introduction 
 Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. More than 33 
million individuals are estimated to have AF globally.1 In the United States (US) alone more than 
3 million people are currently affected by AF, with a projected increase to 8 million by the year 
2050.2 Individuals with AF utilize a wide variety of inpatient and outpatient healthcare services. 
Globally and across studies, inpatient services account for the majority of AF spending.3,4 The 
direct cost of AF treatment in the US is 6.65 billion dollars annually, and hospitalizations with a 
principle discharge diagnosis of AF account for the majority of spending (2.93 billion dollars, 
44%).4 Ambulatory and outpatient treatment costs an estimated 1.76 billion annually, 17% of 
which is attributable to emergency department (ED) visits.4 Symptoms are a major predictor of 
hospitalizations among individuals with AF.5 
Given the substantial cost of AF treatment, it is crucial to ensure adequate outpatient 
symptom management for AF, which could reduce hospitalizations and ED visits. Unfortunately, 
AF symptoms are poorly understood and little is known regarding the mechanisms of AF 
symptoms.6 For instance, AF symptoms do not always correlate with episodes of arrhythmia,7-9 
making it challenging to know the best approach to symptom management for some patients. The 
scant research on AF symptoms provides does not provide specific information regarding which 
symptoms, or combinations of symptoms, are the most likely to result in healthcare utilization.  
The examination of symptom clusters is a previously unexplored area of AF symptom research 
that may help us better understand the relationship between symptoms and healthcare 
utilization.10 Symptom clusters are groups of 2 or more symptoms that are related due to shared 
mechanisms, covariance, or effect on outcomes. For this study, we define symptom clusters as 
two or more co-occurring symptoms.20,21 If symptom clusters can be identified that are associated 
with healthcare utilization, we can use that information to develop tailored interventions aimed at 
reducing unnecessary ED visits and avoidable hospitalizations. As such, the purpose of this study 
was three-fold: 1) to identify AF-specific symptom clusters, 2) to characterize individuals within 
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each identified symptom cluster, and 3) to determine whether symptom cluster membership is 
associated with healthcare utilization (AF-related hospitalizations and ED visits).  
Methods 
 We conducted a cross-sectional secondary data analysis using de-identified data from 
the Vanderbilt Atrial Fibrillation Registry (VAFR).11 VAFR is a single center clinical biorepository 
that prospectively enrolled AF patients and their family members beginning in October 2002. The 
registry was approved by the Vanderbilt University Institutional Review Board (IRB), and this 
secondary data analysis was approved by the University of Pennsylvania IRB.  
Study Population 
 Consecutively enrolled patients from Vanderbilt cardiology clinics, ED, and in-patient 
services are captured in VAFR11-13. Inclusion requirements were documented AF or atrial flutter 
and age of 18 years or greater. AF was documented on an electrocardiogram (ECG), Holter 
monitor, rhythm strip, or event recorder. AF was defined as replacement of p-waves with rapid 
oscillations that varied in size, shape, and timing and were accompanied by irregular ventricular 
response when atrioventricular conduction was intact. Patients were excluded from VAFR if AF 
was only present within the first 90 days after cardiac surgery or were unable/unwilling to provide 
written informed consent.  
Our sample for this study consists of the 1,501 adults in the VAFR clinical registry with a 
confirmed diagnosis of AF and a completed baseline symptom survey. We excluded from our 
analysis individuals who had atrial flutter but not AF, and individuals who did not complete a 
baseline symptom survey.  
Measurement of Variables 
Demographic and Clinical Characteristics 
 Upon enrollment in VAFR, a detailed sociodemographic, medical, and drug history was 
obtained for all participants using an investigator designed form in RedCap14 to standardize data 
collection. Data were collected by trained study personnel (registered nurses) using a 
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combination of patient-report and medical record review. We used the following variables to 
characterize participants in our study: age at consent, gender, ethnicity, body mass index (BMI), 
ejection fraction, left atrial diameter, AF type (paroxysmal, persistent, or permanent), age of AF 
onset, current use of anti-arrhythmic medication, current use of other cardioactive medications, 
history of ablation, history of coronary bypass, heart failure, coronary disease, valve disease, 
hypertension, and CHADS2 score. The CHADS2 score is commonly used to estimate stroke risk; 
scores range from 0 (least risk) to 6 (most risk) and are calculated by assigning one point each 
for the presence of heart failure (C), hypertension (H), age 75 or older (A), or diabetes (D), and 
two points for prior stroke/transient ischemic attack (S).15 We calculated AF duration by 
subtracting age of AF onset from age at consent. Paroxysmal AF was defined as AF that lasted 
for at least 30 seconds and terminated spontaneously. Persistent AF was defined as AF that 
lasted for 7 days or longer and required electrical or chemical cardioversion. Permanent AF was 
defined as continuous AF for which the decision was made not to restore sinus rhythm. Left atrial 
diameter and ejection fraction were recorded on all participants from the echocardiogram or 
magnetic resonance imaging performed closest to the time of enrollment.  
Atrial Fibrillation Symptoms 
 Participants completed the University of Toronto AF Severity Scale (AFSS) upon 
enrollment.11,16,17 The AFSS is a 19-item survey composed of three sections: The first measures 
general life satisfaction and the global frequency, duration, and severity of AF episodes, the 
second measures healthcare utilization, and the third is a symptom subscale that measures the 
presence and frequency of seven of the most common AF symptoms (palpitations, shortness of 
breath at rest, shortness of breath with activity, exercise intolerance, dizziness, fatigue at rest, 
and chest pain).17 Specifically, the following is asked of each specific symptom: how often have 
you been bothered by (palpitations) in the past 4 weeks. Subjects respond on a 6 point Likert 
scale ranging from none (1) to a great deal (6), and total scores for the symptom subscale range 
from 0 to 35. The internal consistency (Cronbach’s α) for AF burden is 0.94.18 Internal 
consistency and test-retest reliability for the symptom subscale have not been reported, however 
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the AFSS has been used in the validation of other AF-specific disease severity and quality of life 
scales, including the Canadian Cardiovascular Society Severity in AF scale (CCS-SAF).19 CCS-
SAF is a physician-rated measure of symptom severity, documented correlation between 
arrhythmia and symptoms, and AF-related functional impairment with scores ranging 0-4. 
Between CCS-SAF class 0 and 4, there was more than a four-fold increase in the AFSS symptom 
subscale scores, demonstrating the ability of this subscale to discern clinically meaningful 
differences in symptoms. We used the symptom subscale of the AFSS as our measure for the 
symptom cluster analysis.  
Healthcare Utilization  
 The second section of the AFSS11,16 measures participants’ utilization of healthcare 
services. Specifically, participants report whether they have ever been cardioverted and how 
many times, along with how many hospitalizations, ED visits, and specialist clinic visits they have 
had within the past 12 months related to their AF. The AFSS was collected by the study nurses 
either by telephone or during clinic visits. We examine two of these variables, hospitalizations and 
ED visits, because they represent AF-specific healthcare utilization that could potentially be 
reduced with improved symptom management and self-care. The healthcare utilization section of 
the AFSS has a low but acceptable 3-month test-retest reliability of 0.71 and internal consistency 
(Cronbach’s α) of 0.67.18  
Statistical Analysis 
 All analyses were conducted using SAS version 9.4 (Cary, North Carolina). Standard 
descriptive statistics were used to describe the data. Symptom clusters were identified with 
agglomerative hierarchical cluster analysis, using Ward’s method and Euclidean distance as our 
dissimilarity measure.22-25 Cluster analysis maximizes the heterogeneity between clusters while 
simultaneously minimizing the homogeneity within clusters.23,24 To determine the ideal number of 
clusters we used dendrograms, pseudo F, and pseudo T.23,26  
 Once symptom clusters were identified, we looked for associations between cluster 
membership and sociodemographic and clinical variables. To do this, we first dichotomized the 
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symptom variables: if a symptom was rated no (1), very little (2), or a little (3) it was dichotomized 
as no/inexistent, whereas if a symptom was rated a fair amount (4), a lot (5), or a great deal (6) it 
was dichotomized as yes/existent. Next, we divided participants into three groups for each 
symptom cluster: those with none, some, or all of the symptoms in the cluster. Next, we 
compared characteristics of the individuals within each group (none/some/all) for each of the 
identified symptom clusters. Comparisons were made with Fisher’s exact or chi-square tests for 
categorical variables and Kruskal-Wallis one-way analysis of variance for continuous and ordinal 
variables. We compared a broad range of sociodemographic and clinical characteristics and a p-
value of < 0.05 was considered statistically significant. 
 Our next step was to conduct two separate regression analyses to determine the 
association between 1) symptom clusters and number of AF-related hospitalizations, and 2) 
symptom clusters and number of AF-related ED visits. We used Poisson regression to model 
both of our outcome variables, AF-related hospitalizations and AF-related ED visits. 
Sociodemographic and clinical variables that were significant when comparing characteristics 
between individuals with none/some/all symptoms in a cluster were entered into our adjusted 
analyses as independent variables. Additionally, other potential confounders were included in the 
adjusted model if they were known a priori to be associated with healthcare utilization or if they 
changed the strength of the association between the symptom clusters and the response variable 
by more than 10%.  
Results 
Sample Characteristics 
 The mean age of participants was 58.4 years (±12.2), ranging between 18.1 and 88.5 
years (Table 3.1). Participants were predominantly Caucasian (96%) and primarily male (67%). 
Exercise intolerance was the most common symptom, affecting 42% of participants, followed by 
shortness of breath with activity (40%) and palpitations (33%). The majority of the sample had 
paroxysmal (51%) or persistent (42.5%) AF, with only a small portion having permanent AF 
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(6.5%). Average AF duration was 4.5 (± 5.8) years. Approximately half the sample was on an 
anti-arrhythmic medication (55%) and/or had a prior catheter or surgical ablation (52%). 
Table 3.1: Demographic and Clinical Profile of VAFR Participants 
                                                                      All (N=1,501) Female (N=497, 33%) Male (N=1,004, 67%) 
Demographic Profile 
   
Age (years) 58.4 (±12.2) 60.9 (±12.8) 57.1 (±11.7) 
Ethnicity 
   
     Caucasian 1,436 (95.7%) 473 (95.2%)  963 (95.9%) 
     Asian 4 (0.3%) 0 (0%)  4 (0.4%) 
     Black 53 (3.5%) 23 (4.6%) 30 (3%) 
     Hispanic 6 (0.4%) 1 (0.2%) 5 (0.5%) 
     Native American 2 (0.1%)  0 (0%) 2 (0.2%) 
Clinical Profile 
   
AF Sub-Type 
   
     Paroxysmal 765 (51.1%) 308 (62.1%) 457 (45.6%) 
     Persistent 636 (42.5%) 164 (33.1%) 472 (47.1%) 
     Permanent 97 (6.5%) 24 (4.8%) 73 (7.3%) 
AF Duration 4.5 (±5.8) 4.3 (±5.3)) 4.6 (±6.0) 
Body Mass Index 31.1 (±6.6) 30.8 (±7.5) 31.2 (±6.1) 
CHADS2 score 1.1 (±1.0)  1.2 (±1.0) 1.0 (±1.0) 
Left Atrial Diameter 42 (±7.8) 43.1 (±7.7) 39.8 (±7.6) 
Heart Failure 216 (14.4%) 69 (13.9%) 147 (14.7%) 
Hypertension 927 (62.0%) 313 (63.1%) 614 (61.5%) 
Coronary Artery Disease 317 (21.3%) 73 (14.8%) 244 (24.5%) 
Valve disease 391 (26.8%) 165 (34.0%) 226 (23.2%) 
History of AF ablation 771 (52.4%) 253 (52.1%) 518 (52.5%) 
History of Cardiac Bypass 
Surgery 
109 (7.3%) 14 (2.9%) 95 (9.5%) 
Digoxin 213 (14.4%)  78 (16.0%) 135 (13.6%) 
Calcium Channel Blocker 468 (31.6%) 165 (33.7%) 303 (30.5%) 
Beta Blocker 730 (49.2%) 241 (49.2%) 489 (49.2%) 
Anti Lipidemic 630 (42.5%) 191 (39.1%) 439 (44.1%) 
Ace/Angiotensin Blocker 591 (39.8%) 187 (38.2%) 404 (40.6%) 
Anti-Arrhythmic 817 (55.1%) 274 (56.0%) 543 (54.6%) 
Symptom Profile 
   
Chest Pain  206 (13.7%) 95 (19.1%) 111 (11.1%) 
Dizziness 289 (19.3%) 140 (28.2%) 149 (14.8%) 
SOB at Rest 297 (19.8%) 127 (25.6%) 170 (16.9%) 
SOB with Activity 599 (39.9%) 239 (48.1%) 360 (35.9%) 
Exercise Intolerance 623 (41.5%) 259 (52.1%) 364 (36.3%) 
Fatigue at Rest 359 (23.9%) 159 (32.0%) 200 (19.9%) 
Palpitations 494 (32.9%) 221 (44.5%) 271 (27.2%) 
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Symptom Clusters 
A three cluster solution was indicated as the optimal solution based on the dendrogram, 
pseudo-F, and pseudo-T (Figure 3.1). One of the clusters in the three cluster solution consists of 
a single symptom (palpitations), and therefore does not meet our definition of a symptom cluster 
(two or more co-occurring symptoms).20,21 We labeled the two clusters that met our definition of a 
symptom cluster the At Rest cluster (fatigue at rest, shortness of breath at rest, chest pain, and 
dizziness) and the With Activity cluster (shortness of breath with activity and exercise 
intolerance). The With Activity symptom cluster was the most common, with all symptoms being 
experienced in 32.7% (n=491) of participants. All the At Rest cluster symptoms occurred in 3.7% 
(n=56) of participants (Table 3.2). There was significant co-occurrence of the two clusters, with 51 
of the 56 participants who had the At Rest cluster also having the With Activity cluster (Table 3.2). 
 
Figure 3.1: Dendrogram of symptom clusters. Symptoms were self-reported at baseline 
 
Between-Cluster Sum of Squares 
Cluster Analysis 
Exercise 
Intolerance 
Short of Breath 
with Activity 
Dizziness 
Chest Pain 
Fatigue at Rest 
Short of Breath at 
Rest 
Palpitations 
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Table 3.2: Cluster Co-occurrence within VAFR  
Palpitations At Rest With Activity 
Palpitations 494 (32.9%) 47 (3.1%) 268 (17.8%) 
At Rest 
 
56 (3.7%) 51 (3.4%) 
With Activity 
  
491 (32.7%) 
  
Characteristics by Symptom Cluster Membership 
Several sociodemographic and clinical characteristics varied by cluster membership. 
Women comprised the greatest proportion of the group that had all symptoms in the At Rest 
cluster (52% women versus 48% men, p<0.0001), even though the overall sample was two thirds 
male. Statistically significant differences in ethnicity, body mass index, coronary disease, heart 
failure, current use of anti-arrhythmic medication, and history of ablation were also apparent. 
Table 3.3 provides full details regarding the differences in sociodemographic and clinical 
characteristics between participants with all, some, and none of the symptoms in the At Rest 
cluster. 
For the With Activity cluster, women were again more likely than men to have all of the 
symptoms in the cluster. Among the group with all of the With Activity symptoms, 59% were male 
and 41% were female (p<0.0001), but due to the larger proportion of men in the study this 
represents 3% of all men and 6% of all women. Participants with none of the With Activity 
symptoms were approximately 2 years younger on average than individuals with all of the 
symptoms (57.5 years versus 59.5 years, p=0.01). AF type varied between individuals with none, 
some, or all of the symptoms in the With Activity cluster (p<0.0001). Additional sociodemographic 
and clinical factors that showed statistically significant variance by cluster membership included 
body mass index, ejection fraction, coronary disease, heart failure, current use of anti-arrhythmic 
medication, and history of ablation (Table 3.3). 
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Table 3.3: Demographic and Clinical Characteristics by VAFR Cluster Membership 
 At Rest 
 None of the 
Symptoms 
N=892 
Some of the 
Symptoms 
N=553 
All of the 
Symptoms 
N=56 
p-value 
Gender    <0.0001 
     Male 664 (74%) 313 (57%) 27 (48%)  
     Female 228 (26%) 240 (43%) 29 (52%)  
Age (years) 58.2 (12.4±) 58.9(12±) 55.8 (10.1±) 0.09 
Caucasian Ethnicity 851 (95%) 535 (97%) 50 (89%) 0.03 
AF Duration (years) 4.6 (6.1±) 4.3 (5.3±) 4.1 (4.4±) 0.95 
AF Sub-Type    0.49 
     Paroxysmal 457 (51%) 284 (51%) 24 (43%)  
     Persistent 371 (42% 235 (43%) 30 (54%)  
     Permanent 62 (7%) 33 (6%) 2 (4%)  
Body Mass Index 30.5 (6.2±) 31.8 (7.1±) 32.4 (7.2±) 0.003 
Ejection Fraction 55.6 (9.9±) 54.7 (10.5±) 54.8 (9.8±) 0.24 
Coronary Disease 156 (18%) 148 (27%) 13 (23%) 0.0002 
Heart Failure 99 (11%) 101 (18%) 16 (29%) <0.0001 
Anti-Arrhythmic  435 (49%) 344 (63%) 38 (67%) <0.0001 
History of Ablation 417 (48%) 313 (58%) 41 (75%) <0.0001 
 With Activity 
 None of the 
Symptoms 
N=770 
Some of the 
Symptoms 
N=240 
All of the 
Symptoms 
N=491 
p-value 
Gender    <0.0001 
     Male 569 (74%) 146 (61%) 289 (59%)  
     Female 201 (26%) 94 (39%) 202 (41%)  
Age (years) 57.5 (12.5±) 58.9 (12.1±) 59.5 (11.8±) 0.01 
Caucasian Ethnicity 734 (95%) 231 (96%) 471 (96%) 0.78 
AF Duration 4.6 (6.2±) 4.6 (5.6±) 4.3 (5.1±) 0.89 
AF Sub-Type    <0.0001 
     Paroxysmal 445 (58%) 120 (50%) 200 (41%)  
     Persistent 272 (35%) 107 (45%) 257 (52%)  
     Permanent 50 (7%) 13 (5%) 34 (7%)  
Body Mass Index 30 (6±) 30.8 (6.5±) 32.7 (7.2±) <0.0001 
Ejection Fraction 55.9 (9.1±) 55.4 (10.4±) 54.2 (11.3±) 0.03 
Coronary Disease 121 (16%) 59 (25%) 137 (28%) <0.0001 
Heart Failure 65 (8%) 36 (15%) 115 (23%) <0.0001 
Anti-Arrhythmic  375 (49%) 145 (61%) 297 (62%) <0.0001 
History of Ablation 334 (44%) 135 (58%) 302 (63%) <0.0001 
Statistically significant p-values (p<0.05) are shown in bold. Data are mean (± standard deviation) 
or number of patients (%). 
 
Impact of Symptom Clusters on Healthcare Utilization 
Emergency Department Utilization 
 In unadjusted analyses, experiencing all the symptoms in the At Rest cluster more than 
tripled the rate of ED utilization (incident rate ratio 3.6, p<0.0001, Table 3.4), while having all the 
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symptoms in the With Activity cluster resulted in more than one and a half times the rate of ED 
utilization (incident rate ratio 1.6, p<0.0001). In the adjusted model, the With Activity cluster no 
longer had a statistically significant association with ED utilization (incident rate ratio 0.96, 
p=0.6604). Experiencing all the symptoms in the At Rest cluster had the strongest association 
with ED utilization of all variables in the model, resulting in nearly triple the rate of ED utilization 
compared to individuals with none of the At Rest symptoms (incident rate ratio 2.8, p<0.0001). 
The symptom ‘palpitations’ did not cluster with other symptoms, but on its own did result in a 
slightly increased rate of ED utilization in the adjusted model (incident rate ratio 1.17, p=0.046). 
We did an exploratory analysis of interactions between AF type and both history of ablation and 
current use of anti-arrhythmic medication and none were statistically significant. However, 
individuals with permanent AF and a history of ablation had nearly twice the rate of ED utilization 
as individuals with paroxysmal AF (incident rate ratio 1.8, p=0.45). 
Table 3.4: At Rest Cluster Emergency Department Utilization 
At Rest Cluster Unadjusted 
IRR/p-value 
Adjusted* 
IRR/p-value 
None (ref) (ref) 
Some 1.663/<0.0001 1.423/<0.0001 
All 3.643/<0.0001 2.767/<0.0001 
*adjusted for gender, age, AF type, history of ablation, current AAD, heart failure, palpitations, body mass 
index, coronary disease, left ventricular ejection fraction, AF duration 
 
Hospitalizations 
 Experiencing all the symptoms in the At Rest cluster nearly tripled the rate of 
hospitalizations in unadjusted analyses (incident rate ratio 2.8, p<0.0001), whereas having all 
symptoms in the With Activity cluster corresponded with more than one and a half times the rate 
of hospitalizations (incident rate ratio 1.7, p<0.0001, Table 3.5). In the adjusted model, the With 
Activity cluster no longer had a statistically significant association with hospitalizations (incident 
rate ratio 0.98, p=0.85). Among the retained variables, having all symptoms in the At Rest cluster 
was the most strongly associated with hospitalizations, resulting in almost twice the rate of 
hospitalizations compared to individuals with none of the At Rest symptoms (incident rate ratio 
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1.9, p<0.0001). Palpitations also increased the rate of hospitalizations in the adjusted model 
(incident rate ratio 1.27, p=0.002). Exploratory testing of interactions between AF type and both 
history of ablation and current use of anti-arrhythmic medication resulted in no statistically 
significant interactions. However, individuals with permanent AF and current use of anti-
arrhythmic medications had over twice the rate of hospitalization as individuals with paroxysmal 
AF (incident rate ratio 2.2, p=0.24).  
Table 3.5: At Rest Cluster Hospitalizations  
At Rest Cluster Unadjusted 
IRR/p-value 
Adjusted* 
IRR/p-value 
None (ref) (ref) 
Some 1.719/<0.0001 1.340/ 0.0001 
All 2.799/<0.0001 1.904/<0.0001 
*adjusted for gender, age, ethnicity, AF type, history of ablation, current AAD, heart failure, palpitations, 
body mass index, coronary disease, left ventricular ejection fraction, AF duration 
 
Discussion 
Using a large sample of adults with clinically verified AF, we identified two AF-specific 
symptom clusters: The At Rest cluster (fatigue at rest, shortness of breath at rest, chest pain, and 
dizziness) and the With Activity cluster (shortness of breath with activity and exercise 
intolerance). Experiencing all symptoms in the At Rest cluster conferred significant risk for both 
ED utilization and hospitalization. These findings are consistent with prior research which shows 
that severe European Heart Rhythm Association (EHRA) symptom scores (defined as symptoms 
that effect daily activities) are a major predictor of incident hospitalizations in patients with AF.5 
Recent research also indicates that individuals who experience AF symptoms that are readily 
attributable to cardiac causes (i.e. chest pain or dizziness) are more likely to seek treatment in a 
timely manner (<24 hours).27 This offers a logical explanation as to why the At Rest cluster of 
symptoms is more likely to result in ED utilization than others.  
The clusters identified in this study differ from the previously reported AF-specific 
symptom clusters identified using participants in the SAFETY trial.10,28 The symptom clusters 
identified with SAFETY included a vagal cluster (nausea and diaphoresis), tired cluster (fatigue, 
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weakness, syncope/dizziness, and dyspnea), and heart cluster (palpitations and chest pain).10 
Differences between the VAFR and SAFETY recruitment strategies, inclusion criteria, and 
approach to symptom measurement likely account for the differences between the symptom 
clusters found in these studies. Participants in VAFR were recruited from both inpatient and 
outpatient settings, whereas SAFETY participants were all recruited during an inpatient 
admission. The symptom profiles of individuals requiring inpatient management likely differ from 
those of individuals in an outpatient environment.5 This discrepancy could account for differences 
in symptom profiles that potentially affected the symptom cluster results. A second important 
difference between VAFR and SAFETY participants is that individuals with heart failure were 
excluded from SAFETY but were included in VAFR. Comorbid heart failure likely impacts 
symptoms and symptom clusters, by affecting either the severity or the type of symptoms 
reported.29 Another important difference between the two studies was the method of symptom 
measurement. Both studies used parsimonious symptom scales, but the specific symptoms 
measured varied. The differences in the inclusion criteria and symptoms measured likely 
impacted the results of the symptom cluster analyses.  
The symptom of palpitations did not cluster with other symptoms in the present study. 
However, palpitations independently increased the risk of both ED utilization and hospitalization. 
Recent studies reveal that approximately 75% of patients presenting to the ED for AF report 
palpitations.30,31 In a prior study of AF symptom clusters using SAFETY28 trial participants, 
palpitations clustered with chest pain.10 It is possible that if a comprehensive rather than 
parsimonious symptom scale were used, that palpitations would cluster with other symptoms. 
Regardless of clustering, palpitations should be considered a symptom that increases a patient’s 
risk for ED utilization and hospitalization, and therefore patients may benefit from symptom 
management and self-care strategies.  
Several statistically significant differences were noted in the sociodemographic and 
clinical characteristics of individuals with the At Rest and With Activity symptom clusters. 
Individuals with all of either the At Rest or With Activity symptom clusters were more likely to be 
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on anti-arrhythmic therapy, have a history of ablation, be female, have an elevated BMI, and have 
heart failure. Consistent with clinical recommendations,32 our findings indicate that rhythm control 
strategies (anti-arrhythmic medications and ablation) were more commonly used for individuals 
with significant symptom burden.  
Our finding that women are more likely to experience both the At Rest and With Activity 
symptom clusters is consistent with prior research related to AF symptom clusters, which similarly 
found that women were more likely to experience a cluster of palpitations and chest pain.10 In 
fact, the majority of AF symptom literature indicates that  women report more frequent and severe 
symptoms than men.33-35   
Obesity is a known risk factor for increased AF burden and symptom severity,36,37 and our 
findings provide further evidence of the relationship between obesity and AF symptoms. The 
association between obesity and AF symptom severity may be confounded by physical inactivity 
and depression,38 indicating two modifiable factors that could be targeted in interventions aimed 
at improving AF symptom management and self-care.  
AF and heart failure have many symptoms in common (e.g. shortness of breath, fatigue), 
so it is not surprising that individuals with heart failure were more likely to experience both 
symptom clusters. Concomitant heart failure and AF may further exacerbate each other due to 
the effects of each on hemodynamic function,32 making symptomatic management of both 
conditions more challenging. Pre-existing heart failure is a primary predictor for hospitalization 
among patients with AF (hazard ratio 1.57),5 indicating symptomatic AF patients with heart failure 
may benefit the most from interventions designed to improve AF symptom management and self-
care.  
Our findings reveal that individuals with all the symptoms in the With Activity cluster tend 
to be older and have persistent or permanent AF. This information is useful for clinical evaluation, 
suggesting the importance of careful assessment in this patient population for these intermittent 
and vague symptoms which prior research indicates are often attributed to other causes (e.g. 
aging, deconditioning).27  
49 
 
 
To date, symptom management for AF has largely been focused on rate and/or rhythm 
control strategies via medical or surgical management.32 Studies of self-care strategies to 
improve symptom management are largely lacking, and the few studies published are in the early 
stages of intervention development.39-41 Self-care is defined as the decision making processes 
that individuals use to maintain health and manage illness, with symptom perception 
acknowledged as having a profound impact on self-care outcomes.42 Health-promoting lifestyle 
choices are an important component of self-care (e.g. nutritious diet, exercise) which are 
beginning to be explored as options for AF symptom management.36,37,43,44 Additional research is 
warranted to explore the effect of self-care interventions on AF symptoms and healthcare 
utilization. 
Limitations 
 There are several important limitations to our study. First, our study lacks both 
psychological comorbidities (e.g. depression, anxiety) and symptoms (e.g. worry, fear). 
Psychological comorbidities have been shown to influence both the number and severity of AF 
symptoms.8,35 Psychological symptoms may be important components of symptom clusters, but 
we were unable to examine this possibility since they are not measured with the AFSS. Future 
prospective studies of AF symptom clusters should include psychological covariates. Second, it 
may be beneficial to use a more comprehensive symptom scale for future AF symptom cluster 
studies (e.g. the Symptom Checklist45,46). The AFSS is a parsimonious, validated symptom scale 
which is appropriate for clinical practice and certain research questions. However, a more 
comprehensive scale could provide clarity regarding the different clusters found in this study and 
our prior work.10 Third, our sample was primarily Caucasian and male, however AF is more 
common in this demographic47,48 and as such does not necessarily limit the generalizability of our 
findings. Finally, the healthcare utilization outcome variables were self-reported. The variables 
were collected with the validated AFSS healthcare utilization subscale, and participants were only 
asked to recall hospitalizations and ED visits within the past 12 months, therefore we believe 
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participants recall is likely accurate. However, future studies using medical record review or 
claims data should be conducted to confirm our findings. 
Conclusion 
 This study provides evidence of two AF-specific symptom clusters. The At Rest cluster of 
symptoms increases a patient’s risk for healthcare utilization. These results should be confirmed 
with additional studies. Symptom are quick and easy to assess, and therefore our results offer a 
useful tool that can aid in clinical decision making and risk-stratification for patients with AF.   
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CHAPTER 4: LATENT CLASS REGRESSION ANALYSIS IDENTIFIES SYMPTOM CLUSTERS 
AMONG ADULTS WITH ATRIAL FIBRILLATION THAT INCREASES HOSPITALIZATIONS AND 
EMERGENCY DEPARTEMENT VISITS 
Abstract 
Background: Symptom clusters among adults with atrial fibrillation may influence healthcare 
utilizations. This is the first study to use latent class analysis to evaluate symptom clusters among 
adults with atrial fibrillation. Objective: The purpose of this study was to: 1) identify clusters of 
patients with similar symptom profiles, 2) characterize the individuals within each cluster, and 3) 
determine whether specific symptom profiles are associated with healthcare utilization (AF-
related hospitalizations and ED visits). Methods: This was a cross-sectional secondary data 
analysis of 1,291 adults from the Vanderbilt Atrial Fibrillation Registry with clinically verified 
paroxysmal, persistent, or permanent atrial fibrillation. We used self-reported symptoms and 
latent class analysis to determine symptom clusters, with clinical and demographic variables 
included as covariates. We then conducted regression analyses to examine the association 
between latent class membership and healthcare utilization (atrial fibrillation related emergency 
department visits and hospitalizations). Results: Participants were predominantly male (67%) 
and ranged in age from 18.9 and 88.5 years, with a mean of 58.4 years (±11.9). Four latent 
classes were evident, including 1) Asymptomatic cluster (N=487, 38%), 2) Highly Symptomatic 
cluster (N=142, 11%), 3) With Activity cluster (N=326, 25%), and 4) Mild Diffuse cluster (N=336, 
26%). Membership in the Highly Symptomatic and With Activity clusters resulted in significantly 
increased rates of both emergency department visits and hospitalizations. Conclusion: Clinically 
meaningful atrial fibrillation symptom clusters were identified that increase both emergency 
department visits and hospitalizations. 
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Introduction 
The perception of symptoms is a major factor in the decision to utilize healthcare 
services. Symptom perception refers to both the detection of symptoms and the interpretation of 
symptom meaning.1-4 For individuals with atrial fibrillation (AF), symptoms may be interpreted as 
relatively harmless, resulting in a ‘wait and see’ approach, or might be interpreted as life-
threatening and prompt a decision to seek immediate medical attention.5,6  
Limited data is available regarding the relationship between AF symptoms and healthcare 
utilization outcomes.7 Between 1993 and 2004 emergency department (ED) visits for AF 
increased 88%, and almost 64% of ED visits for AF resulted in a subsequent hospitalization.8 
Two studies using the Outcomes Registry for Better Informed Treatment of AF found that 
symptoms rated as severe with the European Heart Rhythm Association classification system 
were a major predictor of hospitalizations.9,10 However, the relationship between specific AF 
symptoms and healthcare utilization outcomes has not been reported. There are a wide range of 
symptoms experienced by individuals with AF including palpitations, chest pain, shortness of 
breath, dizziness, exercise intolerance, and fatigue.11 It is likely that distinct AF symptoms are 
interpreted differentially, resulting in disparate utilization of healthcare services depending on the 
specific symptoms present.  
Symptom clusters are groups of 2 or more co-occurring symptoms that are related due to 
a shared mechanism, covariance, or effect on patient outcomes.12-15 Symptom clusters likely 
have a unique impact on healthcare utilization due to the multiplicative effect of co-occurring 
symptoms.1 There are two basic approaches to symptom cluster research: 1) clustering symptom 
variables and 2) clustering individuals into mutually exclusive groups with similar symptom 
profiles.14,16 Our prior work on AF symptom clusters used the approach of identifying clusters of 
symptoms.17 To our knowledge, no previous study has sought to identify clusters of AF patients 
who have similar symptom profiles. Understanding the symptom profiles that are associated with 
higher rates of healthcare utilization could improve our ability to risk stratify patients and provide 
individualized support to patients at higher risk for ED visits or hospitalization. The purpose of this 
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study was to: 1) identify clusters of patients with similar symptom profiles, 2) characterize the 
individuals within each cluster, and 3) determine whether specific symptom profiles are 
associated with healthcare utilization (AF-related hospitalizations and ED visits).  
Methods 
This was a cross-sectional secondary data analysis using de-identified data from the 
Vanderbilt Atrial Fibrillation Registry (VAFR),18 a single center clinical biorepository. VAFR 
prospectively enrolled AF patients and their family members beginning in October 2002. 
Institutional Review Board (IRB) approval was obtained from Vanderbilt University for the registry, 
and from the University of Pennsylvania for this secondary data analysis. All VAFR participants 
provided written informed consent.  
Study Population 
 Patients from Vanderbilt cardiology clinics, ED, and in-patient services were 
consecutively enrolled in VAFR18-20. Inclusion requirements were age of 18 years or greater and 
AF or atrial flutter documented with an electrocardiogram (ECG), Holter monitor, rhythm strip, or 
event recorder. AF was defined as replacement of p-waves with rapid oscillations that varied in 
size, shape, and timing and were accompanied by irregular ventricular response when 
atrioventricular conduction was intact. Patients were excluded from VAFR if AF was only present 
within the first 90 days after cardiac surgery. For this study, we included in our sample the 1,501 
adults from the VAFR clinical registry with a confirmed diagnosis of AF and a completed baseline 
symptom survey. We excluded individuals who had atrial flutter but not AF.  
Measurement of Variables 
Demographic and Clinical Characteristics 
 Participants in VAFR had a detailed sociodemographic, medical, and drug history taken 
upon enrollment. An investigator designed REDCap21 form was used to standardize data 
collection. A combination of patient-reported and medical record review data were collected by 
trained study personnel (registered nurses). We used the following variables to characterize 
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participants in our study: age at consent, gender, ethnicity, body mass index (BMI), ejection 
fraction, AF type (paroxysmal, persistent, or permanent), AF duration, current use of anti-
arrhythmic medication, history of ablation, history of coronary bypass, heart failure, and coronary 
disease. We determined AF duration by subtracting the reported age of AF onset from age at 
consent. Paroxysmal AF was defined as lasting for at least 30 seconds and terminating 
spontaneously, persistent AF as lasting for 7 days or longer and requiring electrical or chemical 
cardioversion, and permanent AF as continuous AF for which a decision was made not to restore 
sinus rhythm. The echocardiogram or magnetic resonance imaging performed closest to the time 
of enrollment was used to record the ejection fraction for all participants.  
Atrial Fibrillation Symptoms 
 All participants were asked to complete a symptom survey upon enrollment in VAFR, 
specifically the 19-item University of Toronto AF Severity Scale (AFSS).18,22,23 To measure 
symptoms we used the third section of the AFSS, which is a symptom subscale that provides 
information regarding the presence and frequency of 7 common AF symptoms (palpitations, 
shortness of breath at rest, shortness of breath with activity, exercise intolerance, dizziness, 
fatigue at rest, and chest pain).23 Specifically, participants are asked how often they have been 
bothered by (palpitations) in the past 4 weeks. Subjects respond separately for each symptom on 
a 6 point Likert scale ranging from none (1) to a great deal (6). Total scores for the symptom 
subscale range from 0 to 35. Internal consistency and test-retest reliability for the symptom 
subscale have not been reported. However, the AFSS has been used to validate the Canadian 
Cardiovascular Society Severity in AF scale (CCS-SAF),24 which is a physician-rated measure of 
symptom severity, correlation between arrhythmia and symptoms, and functional impairment, with 
scores ranging 0-4. Between CCS-SAF class 0 and 4, the AFSS symptom subscale scores 
increased more than four-fold, demonstrating the ability of this subscale to discern clinically 
meaningful differences in symptoms.  
Healthcare Utilization  
 The second section of the AFSS18,22 measures if and how often participants were 
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cardioverted, hospitalized, visited the ED, and/or had specialist clinic appointments in the past 12 
months related to their AF. Trained study nurses collected the AFSS either by telephone or during 
clinic visits. We examine two of these healthcare utilization variables, hospitalizations and ED 
visits, because we believe they could be safely reduced with interventions aimed at improving 
symptom management and self-care. The AFSS healthcare utilization section has low but 
acceptable 3-month test-retest reliability (0.71) and internal consistency (Cronbach’s α, 0.67).25  
Statistical Analysis 
 Clusters were identified using latent class analysis, a type of finite mixture model.26 
Latent class analysis allows for the simultaneous examination of relationships between multiple 
variables, covariates, and outcomes.16,26 The goal of latent class modeling is to stratify 
categorical observed (manifest) variables by an unobserved (latent) variable, eliminating 
confounding between the observed variables. The latent class model probabilistically groups 
every observation (patient) into a latent class, which also results in expectations regarding how 
that patient responds to each observed variable in the model. A latent class regression model 
extends the basic latent class model and allows for the inclusion of covariates (independent 
variables), which predict latent class membership.26  
We conducted a latent class regression analysis in R 3.3.0 using the poLCA package.26-28 
We used the 7 symptoms on the AFSS subscale as our manifest (observed) variables. We 
included 11 sociodemographic and clinical covariates (independent variables) in our latent class 
model that were known a priori to be associated with AF symptoms.11,17,24,29-32 Covariates were 
retained in our final adjusted model if they were statistically significant (p < 0.05) or if their 
removal changed the strength of the association between covariates and the latent classes by 
more than 10%. The poLCA package estimates the model by maximizing the log-likelihood 
function. To ensure we found the global maximum of the log-likelihood, we conducted 100 
random start repetitions of our final model. The ideal number of latent classes is not pre-
determined, but is determined using statistical fit indices combined with evaluation of the model 
for theoretical and clinical meaningfulness. The two most widely used fit indices are the Bayesian 
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information criterion (BIC) and Akaike information criterion (AIC), which we used in combination 
with the Pearson’s 𝜒2 statistical test to evaluate our model.26 For each test, lower values equate to 
a better fitting model. The poLCA package provides probabilities by class for each manifest 
variable entered into the model. We define probabilities >0.5 as high, probabilities between 0.2 
and 0.5 as moderate, and probabilities <0.2 as low.  
 Our final step was to conduct two separate regression analyses that used measures of 
healthcare utilization as the dependent variables and latent class membership as the independent 
variable. The first regression analysis used AF-related ED visits as the dependent variable, and 
the second regression used AF-related hospitalizations as the dependent variable. Because 
sociodemographic and clinical covariates that potentially affect symptoms and healthcare 
utilization (e.g. age, comorbidities) were already entered into the latent class regression analysis 
as covariates, we did not use them again in these regression analyses. The healthcare utilization 
regression analyses and standard descriptive statistics were conducted in SAS version 9.4 (Cary, 
North Carolina). We considered p-values of <0.05 statistically significant. 
Results 
Sample Characteristics 
Participants were predominantly male (67%) and ranged in age from 18.9 and 88.5 
years, with a mean of 58.4 years (±11.9). The sample primarily consisted of individuals with 
paroxysmal (51.1%) and persistent (43.6%) AF. Our analytic sample size was reduced to 1,291 
for our final model because poLCA automatically excludes observations with missing values on 
any covariate. We used the chi-square test to compare symptom severities of individuals that 
were and were not included in the analytic sample and found no statistically significant 
differences (p<0.05) in symptoms. Sample characteristics are further detailed in Table 4.1.  
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Table 4.1: Sample Characteristics 
Variable                                                     N=1,291 
Sociodemographic Profile 
 
Age (years) 58.4 (±11.9) 
Male 861 (67%) 
Female 430 (33%) 
Caucasian 1,239 (96%) 
Clinical Profile 
 
AF Sub-Type 
 
     Paroxysmal 660 (51.1%) 
     Persistent 563 (43.6%) 
     Permanent 68 (5.3%) 
AF Duration 4.4 (±5.5) 
Body Mass Index 30.9 (±6.4) 
CHADS2 score 1.1 (±1.0) 
Left Atrial Diameter 41.7 (±7.7) 
Left Ventricular Ejection Fraction 55.5 (±9.9) 
Heart Failure 177 (13.7%) 
Hypertension 800 (62.2%) 
Coronary Artery Disease 270 (20.9%) 
History of AF ablation 713 (55.2%) 
Anti-Arrhythmic Medication 750 (58.1%) 
 
Latent Class Regression Analysis 
Model Selection 
Our analyses indicated that the optimal solution consisted of four classes (Figure 4.1). In 
the initial unadjusted model, fit statistics indicated that either a 3 or 4 class solution could be 
selected. Therefore, we analyzed both the 3 and 4 class solutions when removing covariates to 
adjust the model. In the final 4 class model, 9 of the 11 covariates were retained (only AF 
duration and ethnicity were removed). The fit statistics for the final model did not precisely 
indicate which solution was most appropriate (Table 4.2). The BIC treats Type I and Type II errors 
as equally undesirable, whereas the AIC treats Type II errors as the most undesirable. As a 
result, the AIC is more likely to indicate an overfit model;33 therefore we chose the model 
indicated by the BIC. The symptom profiles of the various solutions were compared, and the 4 
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class solution also made the most theoretical and clinical sense, and as such is considered our 
optimal solution.  
Table 4.2: Statistical Fit Indices 
Number of Classes AIC BIC 𝝌2 
3  23668.95 24314.34 353461.8 
4  23435.95 24313.4 497686.1 
5 23208.67 24318.75 530398.5 
 
 
Figure 4.1: Graphical representation of latent class membership and probability of manifest 
variables  
 
Latent Class Symptom Characteristics by Cluster Membership 
The Asymptomatic cluster consisted of individuals with a high probability of responding 
“none” for every symptom (Table 4.3). This cluster had the highest membership (N=487, 38%). 
The Highly Symptomatic cluster (N=142, 11%) is characterized by a high probability to answer “a 
great deal” for the symptoms of shortness of breath with activity and exercise intolerance, along 
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Highly Symptomatic Cluster: population share = 0.116 
Asymptomatic Cluster: population share = 0.375 
With Activity Cluster: population share = 0.253 
Mild Diffuse Cluster: population share = 0.256 
Palpitations   SOB at Rest  SOB w/ Activity  Exercise Intol. Fatigue at Rest   Dizziness   Chest Pain 
Palpitations   SOB at Rest  SOB w/ Activity  Exercise Intol. Fatigue at Rest   Dizziness   Chest Pain 
Palpitations   SOB at Rest  SOB w/ Activity  Exercise Intol. Fatigue at Rest   Dizziness   Chest Pain 
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with a moderate probability of experiencing a “fair amount” to “a great deal” of palpitations, 
shortness of breath at rest, and fatigue at rest. The With Activity cluster (N=326, 25%) is 
characterized by a moderate probability of experiencing most symptoms in the “a little” to “a lot” 
range. However, the most probable symptoms/symptom ratings in the With Activity cluster are 
shortness of breath with activity and exercise intolerance rated as “a fair amount” and “a lot”. The 
Mild Diffuse cluster (N=336, 26%) is characterized by a moderate probability of experiencing 
most of the symptoms “none”, “very little” or “a little”, and a high probability to report “none” for 
chest pain. In every class, chest pain was highly or moderately likely to be reported as “none”.  
 
Table 4.3: Symptom Probabilities by Cluster Membership 
 Likert Rating Probabilities 
Cluster Membership None Very 
Little 
A Little Fair 
Amount 
A Lot Great 
Deal 
Asymptomatic Cluster  
(N=487, 38%) 
      
Palpitations 0.6362  0.1209 0.1230 0.0677 0.0364 0.0158 
Shortness of Breath at Rest 0.9426  0.0344 0.0176 0.0054 0.0000 0.0000 
Shortness of Breath with Activity 0.7509  0.0722 0.1182 0.0348 0.0157 0.0082 
Exercise Intolerance 0.7654  0.0519 0.1185 0.0352 0.0252 0.0039 
Fatigue at Rest 0.9073  0.0230 0.0361 0.0253 0.0083 0.0000 
Dizziness 0.7866  0.1018 0.0676 0.0411 0.0028 0.0000 
Chest Pain 0.9120  0.0455 0.0298 0.0094 0.0033 0.0000 
Highly Symptomatic Cluster 
(N=142, 11%) 
      
Palpitations 0.1872  0.0387 0.1008 0.1655 0.2347 0.2731 
Shortness of Breath at Rest 0.0800 0.0578 0.0493 0.2655 0.2741 0.2733 
Shortness of Breath with Activity 0.0099  0.0000 0.0179 0.0364 0.1939 0.7418 
Exercise Intolerance 0.0153  0.0139 0.0087 0.1104 0.2533 0.5984 
Fatigue at Rest 0.0718  0.0249 0.1332 0.2987 0.2536 0.2179 
Dizziness 0.1990  0.0359 0.2078 0.1999 0.1835 0.1738 
Chest Pain 0.3408  0.0936 0.1528 0.1698 0.1780 0.0650 
With Activity Cluster 
(N=326, 25%) 
      
Palpitations 0.1891  0.1013 0.1329 0.2802 0.2357 0.0609 
Shortness of Breath at Rest 0.2393  0.1466 0.2405 0.2697 0.1039 0.0000 
Shortness of Breath with Activity 0.0615  0.0180 0.1166 0.3691 0.3849 0.0499 
Exercise Intolerance 0.0325  0.0189 0.0920 0.3463 0.4632 0.0471 
Fatigue at Rest 0.2348  0.0983 0.2289 0.2811 0.1375 0.0194 
Dizziness 0.1972  0.1518 0.2930 0.2292 0.1288 0.0000 
Chest Pain 0.3555  0.1356 0.1935 0.2076 0.0917 0.0161 
Mild Diffuse Cluster  
(N=336, 26%) 
      
Palpitations 0.2310  0.2436 0.2388 0.1571 0.1006 0.0289 
Shortness of Breath at Rest 0.4378  0.3772 0.1530 0.0320 0.0000 0.0000 
Shortness of Breath with Activity 0.0942 0.2997 0.3507 0.2366 0.0113 0.0074 
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Exercise Intolerance 0.1384  0.3132 0.3003 0.2461 0.0021 0.0000 
Fatigue at Rest 0.3888  0.2993 0.1991 0.0975 0.0154 0.0000 
Dizziness 0.3815  0.3137 0.2191 0.0554 0.0184 0.0119 
Chest Pain 0.5973  0.2348 0.1376 0.0280 0.0023 0.0000 
High probabilities (>0.5) are in bold, moderate probabilities (0.2-0.5) are in italics. 
 
Latent Class Covariates by Cluster Membership 
 Eleven sociodemographic and clinical variables that are known to influence AF symptoms 
(e.g. age, gender, comorbidities, AF type, ablation)11,17,24,29-32 or were theoretically likely to 
influence AF symptoms (e.g. ejection fraction)7 were entered into our initial latent class model as 
covariates. Nine of these covariates were retained in the final model, several of which had 
statistically significant variation from the reference class (Asymptomatic cluster). Across each 
cluster, gender and history of ablation were the most consistently associated with cluster 
membership (Table 4.4). Males made up the majority (77%) of the Asymptomatic cluster, 
whereas the male/female split was 50/50 in the Highly Symptomatic cluster, and close to equally 
divided in the With Activity cluster (54.6% male/45.4% female), despite the fact that the overall 
study population was 67% male and 33% female. The Asymptomatic cluster had the lowest 
percentage of patients with prior ablation. Individuals in the Highly Symptomatic cluster were less 
likely than those in the Asymptomatic cluster to have paroxysmal AF (32.4% versus 54.4%), and 
more likely to have persistent AF (61.3% versus 38%), a higher BMI (mean 33.8 versus 30), heart 
failure (33.8% versus 9.2%), and coronary disease (35.9% versus 17.3%). Individuals in the With 
Activity cluster were more likely than those in the Asymptomatic cluster to have a higher BMI 
(mean BMI 32 versus 30), be on anti-arrhythmic medication (69% versus 51%), and have 
coronary disease (28.2% versus 17.3%). The Mild Diffuse cluster was the only group that differed 
significantly by age, with a younger mean age of 56.9 compared to 58.6 for the Asymptomatic 
cluster.  
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Table 4.4: Latent Class Regression Model Covariates by Cluster Membership 
Covariate Asymptomatic 
Cluster 
(N=487) 
Highly 
Symptomatic 
Cluster 
(N=142) 
With Activity 
Cluster 
(N=326) 
Mild Diffuse 
Cluster 
(N=336) 
Gender  # # * 
     Male 377 (77.4%) 71 (50%) 178 (54.6%) 235 (69.9%) 
     Female 110 (22.6%) 71 (50%) 148 (45.4%) 101 (30.1%) 
Age 58.6 (±12.4) 59.8 (±10.5) 59.1 (±12.2) 56.9 (±11.6) * 
AF Type  #  * 
     Paroxysmal 265 (54.4%) 46 (32.4%) 181 (55.5%) 168 (50%) 
     Persistent 185 (38%) 87 (61.3%) 135 (41.4%) 156 (46.4%) 
     Permanent 37 (7.6%) 9 (6.3%) 10 (3.1%) 12 (3.6%) 
Ejection Fraction 56.1 (±9) 52.8 (±12.1) 56.3 (±9.7) 54.8 (±10) 
BMI 30 (±5.7) 33.8 (±7.3) # 32 (±6.9) * 30 (±5.9) 
Anti-arrhythmic 251 (51.5%) 91 (64.1%) 225 (69%) * 183 (54.5%) 
Heart Failure 45 (9.2%) 48 (33.8%) * 46 (14.1%) 38 (11.3%) 
Coronary 
Disease 
84 (17.3%) 51 (35.9%) * 92 (28.2%) # 43 (12.8%) 
Ablation 202 (41.5%) 89 (62.7%) # 220 (67.5%) # 202 (60.1%) # 
Values are expressed as N (%) or Mean (±SD). Covariates that are significantly different from 
reference (Asymptomatic Cluster) are marked with an asterisk (*) for p<0.05, and with a pound 
sign (#) for p<0.001.  
 
Impact of Symptom Clusters on Healthcare Utilization 
Emergency Department Utilization 
  After the latent class regression analysis was complete we conducted our next 
regression analysis, which used latent class membership as the independent variable and AF-
related ED visits as the dependent variable. We used the Asymptomatic cluster as the reference. 
Membership in the Highly Symptomatic cluster was associated with nearly two and a half times 
the rate of AF-related ED visits as the Asymptomatic cluster (incident rate ratio 2.37, p<0.0001). 
The With Activity cluster also had an elevated rate of ED visits, with more than one and a half 
times the ED visits compared to the Asymptomatic cluster (incident rate ratio 1.7, p<0.0001). The 
Mild Diffuse cluster was not associated with a significantly increased rate of ED visits compared 
to individuals in the Asymptomatic cluster (Table 4.5).  
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Table 4.5: Incident Rate Ratios for AF-related ED Visits and Hospitalizations 
 Emergency Visits Hospitalizations 
Cluster Membership IRR p-value IRR p-value 
Asymptomatic Reference Reference Reference Reference 
Highly Symptomatic 2.37 <0.0001 2.36 <0.0001 
With Activity 1.7 <0.0001 1.67 <0.0001 
Mild Diffuse 1.03 0.76 1.22 0.03 
IRR: incident rate ratio 
 
Hospitalizations 
Next, we conducted a regression with latent class membership as the independent 
variable and AF-related hospitalizations as the dependent variable. The Asymptomatic cluster 
was again used as the class of reference. Results are very similar to those for ED visits. 
Membership in the Highly Symptomatic cluster was associated with nearly two and a half times 
the rate of AF-related hospitalizations compared to the Asymptomatic cluster (incident rate ratio 
2.36, p<0.0001). The With Activity cluster had over one and a half times the rate of 
hospitalizations as the Asymptomatic cluster (incident rate ratio 1.67, p<0.0001). Mild Diffuse 
cluster membership also increased the rate of hospitalizations, although to a lesser degree than 
the other clusters. Mild Diffuse cluster membership resulted in 1.22 times the rate of 
hospitalizations (p=0.03) compared to the Asymptomatic cluster (Table 4.5).  
Discussion 
 We discovered 4 clusters of patients with unique symptom and covariate profiles, 
specifically, the: 1) Asymptomatic, 2) Highly Symptomatic, 3) With Activity, and 4) Mild Diffuse 
symptom clusters. When we examined the 4 clusters for differences in rates of healthcare 
utilization, the results revealed that individuals in the Highly Symptomatic and With Activity 
clusters had significantly higher rates of both ED visits and hospitalizations compared to the 
Asymptomatic cluster. Our results confirm prior research, which shows that generalized symptom 
severity is a major predictor of hospitalization among adults with AF.9 Our results expand on this 
prior knowledge by demonstrating that individuals with specific symptom and covariate profiles 
are at particular risk for ED visits and hospitalizations.  
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 The individuals most at risk for both ED visits and hospitalizations belong to the Highly 
Symptomatic cluster. Individuals in this cluster are likely to experience multiple symptoms, in 
particular shortness of breath with and without activity, exercise intolerance, palpitations, and 
fatigue at rest. These individuals are more likely to be obese and have persistent AF, heart 
failure, and coronary disease when compared to individuals in the Asymptomatic cluster. These 
results are congruent with prior research that identifies heart failure,32 coronary disease,30 and 
obesity34 as a risk factors for AF symptoms. Heart failure has also previously been shown to 
increase the risk of hospitalizations among patients with AF.9 Our results augment current 
knowledge by providing a comprehensive and specific symptom and clinical profile of patients 
with an elevated rate of AF-related ED visits and hospitalizations.  
 The Highly Symptomatic cluster was equally split between males and females despite the 
fact that the overall study population was 67% males and 33% female. The With Activity cluster 
similarly had a greater proportion of females than the overall study population. These results are 
consistent with prior research which shows that women are more likely than men to experience a 
significant level of symptoms, negatively impacting their quality of life.35 
The goal of self-care is for patients to adequately monitor, maintain, and manage their 
health.36 For individuals in the Highly Symptomatic or With Activity cluster, self-care interventions 
have the potential to improve AF symptoms and reduce ED visits and hospitalizations. For 
example, weight reduction, cardio-respiratory fitness, and cardiometabolic risk factor 
management reduce AF symptom burden, symptom severity, and arrhythmia recurrence37-39 
making weight reduction and physical activity meaningful self-care goals for individuals with 
symptomatic AF. The standard versus AF specific management strategy (SAFETY) trial40 
compared standard care to nurse managed home and telephone-based follow up for hospitalized 
patients with AF, which included elements related to self-care such as patient/caregiver education 
and medication management, and resulted in an increased proportion of days alive and out of the 
hospital.40 Another important component of AF-specific self-care is heart rate monitoring, which 
can help patients identify the presence of AF when symptoms are vague or non-specific.6 
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Individuals with clinical profiles placing them at risk for increased rates of healthcare utilization 
(i.e. those with heart failure, obesity, and/or coronary disease who are highly symptomatic) are 
ideal candidates for AF-specific self-care interventions. However, to date there are no studies 
reported of comprehensive self-care measures or interventions specific to individuals with AF.  
 Age was not a factor that influenced membership in the Highly Symptomatic or With 
Activity symptom clusters, although members of the Mild Diffuse cluster were approximately 2 
years younger than Asymptomatic cluster members. Consistent with our findings, prior research 
on AF symptom clusters showed that age may vary for some, but not all, symptom clusters.17 In 
that study, AF patients with the cluster of chest pain and palpitations were younger than members 
of other clusters.  
Chest pain and palpitations were uncommon symptoms in this sample, despite prior 
reports indicating they are common symptoms of AF.11,17 Chest pain was likely to be reported as 
absent or infrequent by members of every symptom cluster in our study. Palpitations, a symptom 
commonly associated with AF, had only a low to moderate probability in every cluster we 
identified. These findings are important since chest pain and palpitations are classic cardiac 
symptoms and patients may have difficulty interpreting the less cardiac-specific symptoms in this 
study (e.g. shortness of breath, fatigue). Lack of accurate symptom interpretation influences the 
response to symptoms, possibly delaying early intervention and prompt treatment.5,6 Prompt 
recognition of symptoms and treatment in a non-urgent outpatient setting has the potential to 
reduce utilization of the ED and subsequent hospitalizations. Education for people at-risk for AF 
and with AF should include a focus on the non-specific symptoms that often occur with AF.6,41 
 Using the same data set (VAFR), we previously identified 2 AF-specific symptom clusters 
(the At Rest and With Activity clusters) using cluster analysis, an approach that clustered 
symptoms rather than individuals, and resulted in mutually exclusive clusters of symptom 
variables (Streur, unpublished data). In the present latent class analysis, our approach was to 
cluster individuals, therefore the same symptom may be present in multiple clusters, but differ 
based on the probability of each Likert scale rating. The results of these two studies are 
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complimentary, with both having a With Activity cluster, which is marked by the symptoms 
shortness of breath with activity and exercise intolerance. Further, the At Rest cluster from the 
cluster analysis is similar to the Highly Symptomatic cluster from the latent class analysis, with 
both including individuals who experience shortness of breath at rest, fatigue at rest, chest pain, 
and dizziness. The Highly Symptomatic cluster is additionally marked by shortness of breath with 
activity and exercise intolerance, which is congruent with our prior cluster analysis findings, given 
that 51 out of the 56 individuals with the At Rest cluster also had the With Activity cluster. Similar 
to our cluster analysis with VAFR (Streur, unpublished data), the clusters identified in the present 
latent class analysis do not align with the cluster analysis we conducted using SAFETY trial 
participants.17,40 Reasons for the discrepancy have been previously discussed (Streur, 
unpublished data), and include differences in sample recruitment (SAFETY17,40 recruited only 
from inpatient setting), inclusion criteria (SAFETY17,40 excluded patients with heart failure), and 
the symptom measurement. 
Limitations 
 There are important limitations of our work worth noting. First, our healthcare utilization 
outcomes variables (AF-related ED visits and hospitalizations) from AFSS are self-reported and 
were not verified with medical records. However, the AFSS was obtained by a trained study 
registered nurse either by telephone or in person. Consequently, patients with questions 
regarding their history of AF-related ED visits and hospitalizations had access to study nurses for 
clarification regarding how to accurately complete the AFSS. Second, history of ablation was 
increased for all latent classes (in comparison to the asymptomatic class). Because of limitations 
related to our cross-sectional study design and our de-identified data set, we do not know the 
timing of ablations and what proportion of the hospitalizations reported on the AFSS may be for 
these (typically) planned admissions.  
Conclusion 
 We identified 4 AF-specific symptom clusters using latent class analysis and showed that 
membership in specific clusters is associated with an increased rate of ED visits and 
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hospitalizations. Cluster membership is associated with several sociodemographic and clinical 
factors, most notably gender, AF type, heart failure, coronary disease, and BMI. Additional 
research is warranted to verify if these symptom clusters can be used clinically to identify patients 
at an elevated risk for ED visits or hospitalizations, and whether self-care interventions targeted 
towards these patients could reduce the rate of ED visits and unplanned hospitalizations.  
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CHAPTER 5: CONCLUSION 
Introduction 
 Major gaps in the literature exist in relation to the causes, consequences, and perception 
of AF symptoms.1 AF symptoms negatively impact several important patient outcomes, including 
healthcare utilization rates, quality of life, and functional status. Improved symptom management 
has the potential to positively impact these outcomes. Self-care is an important component of 
chronic disease management that is under-researched among patients with AF, yet has strong 
potential to improve AF symptom management and related outcomes.5 Symptom perception is a 
primary factor influencing self-care decisions.6,7 This body of work focused on AF symptom 
perception and consequences of AF symptoms. The theoretical framework for this work was a 
modification of the Symptoms Experience Model8 and the Symptom Interpretation Model.9 Our 
definition of symptom perception combined detection and interpretation, with co-occurring 
symptoms theorized as having a unique effect on the interpretation and consequent response to 
symptoms.  
 The overarching goal of these studies was to better understand AF symptom perception 
by examining detected symptoms, identifying symptom clusters, and exploring the relationship 
between clusters and healthcare utilization. The specific aims were to: 1) examine symptoms 
detected by adults with AF and identify symptom clusters, 2) characterize individuals within 
symptom clusters based on demographic and clinical characteristics, and 3) determine whether 
symptom cluster membership was associated with healthcare utilization (AF-related 
hospitalizations and ED visits). The purpose of this final chapter is to summarize the results and 
discuss the implications of each specific aim, relate the findings to the underlying theoretical 
model, then provide recommendations for future research and implications for clinical practice. 
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Discussion of Principle Findings 
Identification of Symptom Clusters  
The first aim was to examine symptoms detected by adults with AF and identify symptom 
clusters. This aim was addressed in each of the three manuscripts comprising this work, using 
two data sets (SAFETY10,11 and VAFR12,13) and two different analytic methods (cluster analysis 
and latent class analysis). An overview of the principal findings is contained in Table 5.1. In 
summary, we found 3 symptom clusters using cluster analysis and the SAFETY participants, 2 
symptom clusters using cluster analysis and the VAFR participants, and 4 symptom clusters 
using latent class analysis and the VAFR participants. The clusters found among the SAFETY 
participants differed significantly from those found in the VAFR participants, a thorough 
discussion of which follows. When comparing the results from the two analytic techniques used 
among the VAFR participants, the clusters differ, yet the results are complimentary. The major 
difference was that cluster analysis resulted in 2 clusters and latent class analysis in 4 clusters, 
the additional clusters consisting of an asymptomatic group of participants and a mildly 
symptomatic group of participants.  
Table 5.1 Principal Findings of Specific Aim 1  
Specific Aim 1: Examine symptoms detected by adults with AF and identify symptom clusters 
Study Analytic Technique Principal Findings 
Symptom Clusters in 
Adults with Chronic 
Atrial Fibrillation 
Cluster analysis 
(SAFETY10,11) 
3 clusters identified: 1) Vagal (nausea and 
diaphoresis), 2) Tired (fatigue/lethargy, 
weakness, syncope/dizziness, and 
dyspnea/breathlessness), and 3) Heart 
(chest pain/discomfort and 
palpitations/fluttering) 
Symptom Clusters 
Increase Rate of 
Hospitalizations and 
Emergency Department 
Visits in Adults with 
Atrial Fibrillation 
Cluster analysis 
(VAFR12,13)  
2 clusters identified: 1) At Rest (fatigue at 
rest, shortness of breath at rest, chest 
pain, and dizziness), and 2) With Activity 
(shortness of breath with activity and 
exercise intolerance) 
Latent Class Regression 
Analysis Identifies 
Symptom Clusters 
among Adults with Atrial 
Fibrillation that Increase 
Hospitalizations and 
Emergency Department 
Visits  
Latent class analysis 
(VAFR12,13) 
4 clusters identified: 1) Asymptomatic 
(unlikely to experience any symptoms), 2) 
Highly Symptomatic (likely to experience 
most of the symptoms), 3) With Activity 
(most likely to experience shortness of 
breath with activity and exercise 
intolerance), and 4) Mild Diffuse 
(experience symptoms but only 
infrequently) 
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The symptom clusters identified with SAFETY10,11 and VAFR12,13 differ as detailed in 
Table 5.1. There are several probable explanations for these differential results, including: 1) 
sample recruitment (SAFETY recruited only from inpatient setting whereas VAFR recruited from 
both inpatient and outpatient settings), 2) inclusion criteria (SAFETY excluded patients with heart 
failure whereas VAFR included participants both with and without heart failure), 3) demo-graphic 
characteristics (SAFETY patients were 14 years older on average, were evenly split between 
males and females, and primarily had persistent AF (88%), whereas VAFR patients were 
younger, primarily (67%) male, and only 43% had persistent AF), and 4) symptom measurement 
(SAFETY used a study-specific tool whereas VAFR used the psychometrically validated AFSS). 
Individuals admitted to the hospital for AF likely differ in symptoms and other aspects of their 
clinical profile compared to individuals being seen for AF in an outpatient environment, making 
this an important distinction between the two samples.3 Similarly, comorbid heart failure is known 
to influence AF symptoms,14 therefore this difference in participant profiles could have impacted 
the symptom clusters identified. The most important factor in the different cluster results was 
likely the approach to symptom measurement. First, the symptoms measured in each study were 
different, making it improbable that the clusters identified in each study would be identical. Even 
symptoms that were included in both studies were worded differently (e.g. fatigue/lethargy versus 
fatigue at rest, syncope/dizziness versus dizziness), which could influence whether a participant 
identifies as having that particular symptom. Additionally, participants in VAFR were instructed to 
report symptoms that occurred during the past 4 weeks, whereas SAFTEY participants were 
asked what symptoms they previously or currently experienced with AF, with no time-limitation 
applied. An additional distinction between the two measures was that SAFETY participants 
recorded yes/no responses, whereas VAFR participants could rank the frequency of symptoms 
on a 6-point Likert scale. Finally, SAFETY participants could list “other” symptoms as free-text, 
whereas VAFR participants had no “other” option and could only report the frequency of the 
symptoms listed. The vagal cluster from the SAFETY cluster analysis was composed entirely of 
symptoms reported as “other”. Combined, these differences in the symptom measures likely 
account for the differences between the clusters identified using each respective data set.  
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Results from the two studies that used VAFR data differ but are complimentary. 
Participants with the At Rest cluster (cluster analysis) experienced fatigue at rest, shortness of 
breath at rest, chest pain, and dizziness. Of the 56 participants with the At Rest cluster, 51 also 
had the With Activity cluster (shortness of breath with activity and exercise intolerance). Similarly, 
participants in the Highly Symptomatic cluster (latent class analysis) were likely to experience 
shortness of breath at rest, fatigue at rest, shortness of breath with activity, and exercise 
intolerance, while also having the probability of experiencing chest pain and dizziness although to 
a lesser degree.  
There are no published studies of AF symptom clusters with which to compare this body 
of work. However, the clusters identified were unique compared to clusters reported in other 
cardiovascular patient populations.15 For instance, Riegel16 found three clusters, plus a chest pain 
only group, among patients with acute coronary syndrome. The clusters included a Pain cluster 
(arm, back, shoulder, neck, throat, and jaw pain), a Stress cluster (shortness of breath, sweating, 
nausea, indigestion, dread, and anxiety, and a Diffuse cluster (characterized by multiple low 
frequency symptoms).16 We similarly found a Mild Diffuse cluster (characterized by multiple low 
frequency symptoms ) using latent class analysis, although the symptoms reported were different, 
making these clusters unique from one another. Other studies of individuals with acute coronary 
syndrome17 and acute myocardial infarction18 had similar but different results from the study by 
Riegel,16 indicating that precise replication of results has been an issue in other cardiac 
populations as well. Two studies with heart failure patients identified nearly identical clusters,19,20 
which were labeled as a Physical cluster (dyspnea, difficulty walking/climbing, fatigue, and sleep 
problems) and an Emotional/Cognitive cluster (worry, depressed feelings, and cognitive 
problems), neither cluster clearly resembling any of the clusters we identified among patients with 
AF. However, these studies are not truly comparable with our results since neither of the 
symptom measures we used included any sleep, cognitive, or emotional symptoms, which are 
key components of the heart failure symptom clusters. 
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The use of different symptom measures was the primary weakness of these studies in 
collectively addressing Aim 1. Unfortunately, the lack of comparability between studies is a 
problem in AF symptom research in general, as there is no accepted standard for patient-
reported measurement of symptoms.1 Furthermore, the most commonly used patient-reported 
symptom measures have sparse information published in regards to their development and 
psychometric validation.1,21-25 Several AF symptom scales have recently been developed that 
address this concern, but it is yet to be determined if these newer scales will be widely adopted 
for use.26,27 Additionally, many symptom scales are parsimonious, retaining only those symptoms 
that are the most common,27 or that have the most impact on quality of life.26 However, the 
objectives of symptom cluster research are such that it is better to comprehensively measure 
symptoms rather than using a parsimonious scale.28 For instance, if the goal is to determine 1) 
the underlying mechanism of the cluster, or 2) the patient profile most at risk for an outcome, a 
scale that is too parsimonious could result in the loss of valuable information, as we saw with the 
SAFETY trial data.  
The primary strength of the Aim 1 results is that they address the gap in the AF literature 
related to symptom clusters. The National Institute of Nursing Research considers symptom 
cluster research an innovative and priority topic for symptom science.29 Numerous theoretical 
conceptualizations of the symptom perception process exist, some of which discuss the impact of 
symptom clusters on the perception process.8,9,30-33 We defined symptom perception as a 
complex process that involves the detection and interpretation of symptoms, with clusters of 
symptoms having a unique impact on the interpretation of symptom meaning. The fact that we 
were unable to replicate the symptoms clusters is an indication that additional work is needed to 
understand AF-specific symptom clusters. Failure to precisely replicate clusters has occurred in 
numerous other disease processes, and reflects the need for improved and consistent methods 
for determining symptom cluster occurrence and composition.34 Accordingly, these studies can be 
used for guidance in the design of future research related to AF symptoms and symptom clusters. 
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Clinical and Demographic Characterization of Individuals within Symptom Clusters 
 The second aim was to characterize individuals within symptom clusters based on 
demographic and clinical characteristics. This aim was achieved in each of the manuscripts within 
this body of work. For both approaches using cluster analysis, comparisons were made between 
individuals with none, some, and all symptoms in each cluster. For the latent class analysis, we 
included demographic and clinical covariates in the latent class regression model, which means 
that the covariates help predict class membership.35 An overview of the principal findings for Aim 
2 is available in Table 5.2.  
 Across the studies, certain characteristics consistently varied based on cluster 
membership, specifically gender, age, AF type, and rhythm management therapies (anti-
arrhythmic medication and history of ablation). Other characteristics varied by cluster 
membership in some but not all of the studies, specifically BMI, coronary disease, and heart 
failure. The first analysis conducted was the cluster analysis using SAFETY10,11 participants, and 
BMI was not included as a covariate. We recognized this as a weakness while planning the 
studies that used VAFR12,13 participants, therefore BMI was included as a covariate in the 
subsequent studies. BMI did prove to be an important characteristic, with elevated BMI being 
associated with the majority of symptom clusters in both subsequent studies. Although coronary 
disease did not show statistically significant variation in the SAFETY cluster analysis, it did in both 
VAFR studies. Individuals with heart failure were not included in SAFETY, however, heart failure 
proved to be an important covariate in predicting membership in the Highly Symptomatic cluster 
in the VAFR latent class analysis.  
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Table 5.2 Principal Findings of Specific Aim 2  
Specific Aim 2: Characterize individuals within symptom clusters based on demographic and 
clinical characteristics 
Study Principal Findings 
Symptom Clusters in Adults 
with Chronic Atrial 
Fibrillation 
Heart cluster membership was associated with younger age, 
female gender, anti-arrhythmic medication use, and paroxysmal 
and persistent AF type.  
Symptom Clusters Increase 
Rate of Hospitalizations and 
Emergency Department 
Visits in Adults with Atrial 
Fibrillation 
Female gender, anti-arrhythmic medication use, history of 
ablation, elevated BMI, coronary disease, and heart failure were 
associated with both the At Rest and With Activity clusters.  
Older age, AF type (persistent and permanent), and slightly 
lower ejection fraction were associated with the With Activity 
(but not At Rest) cluster. 
Non-Caucasian ethnicity was associated with the At Rest 
cluster. 
Latent Class Regression 
Analysis Identifies 
Symptom Clusters among 
Adults with Atrial Fibrillation 
that Increase 
Hospitalizations and 
Emergency Department 
Visits  
Gender and history of ablation were consistently associated with 
cluster membership (female gender increased the likelihood of 
being symptomatic). 
Members of the Highly Symptomatic cluster were more likely to 
have persistent AF, higher BMI, heart failure, and coronary 
disease compared to Asymptomatic cluster members.  
Members of the With Activity cluster were more likely to have 
higher BMI, be on anti-arrhythmic medication, and have 
coronary disease compared to Asymptomatic cluster members.  
Members of the Mild Diffuse cluster were more likely to have 
persistent AF and be younger compared to Asymptomatic 
cluster members. 
 
The variables associated with cluster membership in this work are consistent with prior 
research related to AF symptoms. Female gender has consistently been shown to be associated 
with increased symptom severity and frequency.36-39 Our results provide additional support for the 
association between female gender and symptom frequency and severity. Several factors could 
be involved in the gender-based differences in symptom perception. Females may be more 
willing than males to report symptoms, may evaluate the symptoms differently in terms of 
severity, and may experience or interpret the symptoms differently based on physiological 
differences between males and females (i.e. hormone differences). Additionally, heart failure,40 
coronary disease,41 and obesity42-45 have previously been demonstrated as factors influencing AF 
symptom burden, symptom severity, and arrhythmia recurrence. The hemodynamic changes that 
accompany heart failure and coronary disease help to explain the importance of these 
comorbidities on AF symptom presence and severity.1 For example, reduced cardiac output or 
impaired myocardial perfusion would increase a patient’s chance of experiencing reduced 
exercise capacity, shortness of breath, or fatigue. However, AF patients without these 
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comorbidities also experience these symptoms, so it is important to recognize the symptoms may 
be present even in the absence of overt structural heart disease.46 The relationship between 
elevated BMI and the presence of symptom clusters could be due to obesity-related reductions in 
exercise capacity or physical activity, or to other confounding factors such as depression.42,44 The 
With Activity cluster was associated with older age, whereas other clusters were associated with 
younger age (Heart cluster and Mild Diffuse cluster), which helps to explain the previous lack of 
consistent findings in relation to age-related differences in AF symptoms.41,47  Differences in 
cognition, interoceptive ability, and emotional response to symptoms are a likely cause for age 
related differences in symptom cluster experience.48-50 Collectively, these results strengthen the 
evidence base regarding which patients are most at risk for specific symptom profiles.  
Determining Associations Between Symptom Clusters and Healthcare Utilization 
The third aim of this body of work was to determine whether symptom cluster 
membership was associated with healthcare utilization (AF-related hospitalizations and ED visits). 
This aim was accomplished using the VAFR12,13 dataset, and was assessed with two different 
analytic approaches: cluster analysis and latent class analysis. An overview of the principal 
findings is contained in Table 5.3. In summary, we found that certain symptom clusters were 
associated with an increased rate of AF-related hospitalizations and ED visits, either when 
compared to all individuals without that specific cluster (cluster analysis), or when compared to an 
Asymptomatic cluster of patients (latent class analysis).  
The rate of AF-related ED visits and hospitalizations was greatest among those 
individuals in the most symptomatic clusters (At Rest and Highly Symptomatic), while the With 
Activity cluster identified with latent class analysis also demonstrated a statistically significant 
increase in healthcare utilization, although to a lesser degree. These results confirm the 
hypothesis that distinct AF-specific symptom clusters could be identified that were associated 
with AF-related hospitalizations and ED visits.  
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Table 5.3 Principal Findings of Specific Aim 3 
Specific Aim 3: Determine whether symptom cluster membership was associated with 
healthcare utilization (AF-related hospitalizations and ED visits) 
Study Analytic Technique Principal Findings 
Symptom Clusters Increase 
Rate of Hospitalizations and 
Emergency Department 
Visits in Adults with Atrial 
Fibrillation 
Cluster analysis 
(VAFR12,13)  
Patients with all symptoms of the At 
Rest cluster had 2.8 times the rate of 
AF-related ED visits and 1.9 times the 
rate of AF-related hospitalizations 
compared to those with none of the 
symptoms. 
 
Latent Class Regression 
Analysis Identifies Symptom 
Clusters among Adults with 
Atrial Fibrillation that 
Increase Hospitalizations 
and Emergency Department 
Visits  
Latent class analysis 
(VAFR12,13) 
Compared to patients in the 
Asymptomatic cluster, those in the 
Highly Symptomatic cluster had 2.4 
times the rate of AF-related ED visits 
and hospitalizations, while those in the 
With Activity cluster had 1.7 times the 
rate of ED visits and hospitalizations. 
  
Two prior studies from a large-scale observational AF registry reveal that more severe 
European Heart Rhythm Association (EHRA) symptom classification is associated with increased 
rates of hospitalization among patients with AF.3,51 The EHRA score is a physician-assessed AF 
symptom severity scale which rates symptoms as none (1), mild (2), severe (3), or disabling (4).52 
Freeman51 and colleagues found that patients with EHRA scores of greater than or equal to 2 had 
a greater risk of hospitalization (hazard ratio 1.23). Steinberg3 and colleagues found that severe 
symptoms (EHRA score = 3) were predictive of all-cause hospitalizations (hazard ratio 1.37). The 
same authors found that significant comorbid heart failure (rated as New York Heart Association 
class II-IV) was the greatest predictor of all-cause hospitalization (hazard ratio 1.57).3 Our results 
confirm these prior studies in that the clusters with the most severe symptom profiles were 
associated with increased rates of hospitalization. Further, heart failure was a predictive covariate 
for membership in our Highly Symptomatic cluster. Unlike prior studies, our results identify 
specific clusters of symptoms that could be used to identify patients at higher risk for ED visits 
and hospitalizations.  
Haworth33 proposed that effectively meeting a patient’s needs and negotiating a symptom 
management plan requires that healthcare providers understand the meaning patients associate 
with symptoms. A theoretical assumption underlying our hypothesis that AF-specific symptom 
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clusters could be identified that were associated with healthcare utilization was that symptom 
clusters would have a unique impact on symptom meaning compared to the meaning associated 
with individual symptoms. The findings presented here support this assumption, suggesting 
through the impact of symptom clusters on healthcare utilization that symptom clusters likely 
influence the interpretation of symptom meaning. Additional research is warranted to further test 
and confirm the influence of symptom clusters on self-care and symptom management decisions. 
Summary 
 This body of work represents a significant, theoretically based contribution to the AF 
symptom literature, providing evidence that: 1) AF-specific symptom clusters exist, 2) gender, 
age, BMI, heart failure, coronary disease, AF-type, and rhythm control treatment strategies are 
associated with membership in specific clusters, 3) specific symptom clusters and patient profiles 
are associated with AF-related ED visits and hospitalizations. These studies used existing data 
sets to answer new and meaningful questions related to AF symptom perception. The theoretical 
model used to guide these studies posited that: 1) symptom perception is the combination of 
detection and interpretation, 2) demographic and clinical variables influence symptom perception, 
3) co-occurring groups of symptoms (symptom clusters) uniquely influence symptom 
meaning/interpretation, and 4) healthcare utilization is a consequence of differences in symptom 
perception.  
The results are congruent with the theoretical model, indicating that evaluation of 
patients’ symptom detection, demographic, and clinical profile can provide valuable information 
regarding their risk of visiting an ED or being hospitalized for AF. For example, the symptoms 
shortness of breath at rest and fatigue at rest were features of both the At Rest and Highly 
Symptomatic clusters, the two clusters we identified that were associated with the greatest 
increase in rate of ED visits and hospitalizations. Consistent with prior research,3,43 our results 
indicate that heart failure and elevated BMI are clinical factors that may be particularly useful as 
indicators of risk for more severe symptoms and increased rate of ED visits and hospitalizations. 
Clinically, symptom cluster profiling augments prior knowledge and could be combined with other 
88 
 
 
measures (i.e. EHRA52) to identify patients most at risk for AF-related ED visits and 
hospitalizations.  
One limitation of this work is the cross-sectional study design. Additionally, the theoretical 
model used for this work did not depict changes in symptoms over time. Incorporating the 
temporal dimensions of symptoms into symptom theories and research is an ongoing 
challenge.30,31,53 Examining temporal aspects of symptoms may be important for determining 
underlying physiological or psychological mechanisms, predicting responses, designing 
interventions, and improving outcomes. In the present studies, the nature of our data sets meant 
that we could not examine if or how certain time-specific variables (i.e. ablation) changed 
symptom cluster trajectories. Brant30 suggests latent growth curve models that include multiple 
symptoms as well as time-invariant antecedents and outcomes as one potential approach for 
examining changes in symptoms over time.30 Understanding how symptoms change over time 
and relate to each other temporally could improve our ability to design interventions tailored to a 
patient’s specific symptom trajectory and clinical profile.30 Future prospectively designed 
symptom and symptom cluster studies, both observational and interventional, should use 
theoretical models that incorporate temporal dimension and should aim to include temporal 
dimensions in the study design when appropriate.  
Implications for Future Research 
Additional studies are warranted to validate the symptom clusters identified in this body of 
work. It would be preferable to use a widely accepted symptom measure in order to improve 
comparability (e.g. AFSS25,54 or Symptom Checklist21-23). However, it may also be warranted to 
use a comprehensive rather than parsimonious symptom measure for future studies. Using a 
more comprehensive measure of symptoms may help clarify which clusters are reproducible in 
other AF samples, and would ensure valuable information on less common symptoms is gathered 
(e.g. nausea and diaphoresis, which comprised the Vagal cluster). It is warranted to use a 
symptom measure that includes sleep, cognitive, and emotional symptoms, as these types of 
symptoms do occur in AF patients.22,27 In patients with heart failure, a cognitive/emotional 
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symptom cluster increased the risk for shorter event-free survival more than the physical 
symptom cluster, indicating the potential importance of these symptoms in the AF population as 
well.19  
This work focused on AF symptom clusters, but there has been limited research to date 
describing the AF symptom experience in general,55-57 or the experience and influence of 
individual AF symptoms. For example, studies have documented the poor correlation between 
symptoms and actual arrhythmia occurrence,47,58,59 and it would be beneficial to know if certain 
symptoms are more likely than others to correlate with arrhythmia. Research on individual AF 
symptoms is still warranted and should not be neglected.  
A limitation of quantitative symptom cluster research in general is related to the use and 
timing of symptom scales. A defining characteristic of symptom clusters is that they are groups of 
co-occurring symptoms.28,60  For quantitative symptom cluster research, using a scale with a time-
limitation on when the symptoms occurred (i.e. the last 4 weeks) should increase the chance that 
the clusters identified are characterized by co-occurring symptoms. However, even symptoms 
that occurred in the past 4 weeks may not occur concomitantly. An alternative approach would be 
the use of innovative qualitative, mixed-method, or technology-based approaches to symptom 
cluster identification.61-65 For example, MacPherson64 and colleagues developed a computerized 
symptom capture tool (C-SCAT), which is an iPad application that was originally designed to 
assess 30 common cancer symptoms using a combination of graphical images and free text 
responses to capture the symptom experience. This innovative C-SCAT technology has 
subsequently been used to heuristically examine symptom clusters in adolescents and young 
adults with cancer and mid-life women experiencing menopause.62,65  
Quantitative research is generally considered the standard for symptom cluster 
research.34,66,67 Three quantitative approaches have typically been identified as the ideal methods 
for symptom cluster research: cluster analysis, factor analysis, and latent class analysis.15,34,66 
Despite the general consensus that each method is appropriate for identifying clusters, questions 
remain regarding the best approach for statistical determination of symptom clusters. For 
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instance, Chen68 compared hierarchical cluster analysis, principal component analysis, and 
exploratory factor analysis and found that each technique produced different, albeit similar, 
results. This is consistent with the findings of the present dissertation, where cluster analysis and 
latent class analysis produced different although complimentary results. Chen68 concluded that a 
key factor in attaining replication of symptom clusters would be for the research community to 
consistently utilize a common analytical method, and suggested using the approach that results in 
the most clinically meaningful results. Henoch’s69 approach to the problem with consistency was 
to use multiple questionnaires and multiple analytic techniques, then to report the findings that 
were consistently found across different instruments and analytic techniques. A similar approach 
was used in the present study with the SAFETY data, by comparing the hierarchical cluster 
analysis results with exploratory factor analysis in order to validate our findings.70 Alternatively, 
although quantitative methods are generally considered superior in the symptom cluster literature, 
qualitative and mixed-methods research would be an ideal methodological approach for 
determining which statistical technique provides the most clinically meaningful results. Qualitative 
research could be used to independently explore symptom clusters, while mixed-methods would 
be useful for triangulating qualitative and quantitative data in order to confirm symptom clusters 
determined with statistical methods. Further, mixed-methods could be beneficial in determining 
which statistical methods produce clusters that patients themselves recognize and consider 
clinically meaningful.  
We have already discussed two ways in which qualitative research could be beneficial to 
advance symptom cluster research. A third benefit of qualitative research is the avoidance of 
interoceptive bias, or misrepresentation. Interoception refers to an individual’s ability to perceive 
internal bodily sensations.50,71 Once an individual believes a bodily sensation is abnormal, it is 
considered a symptom.72 Interoceptive accuracy varies significantly between individuals and is 
influenced by cognitive and emotional factors that are not yet fully understood.50 When bodily 
sensations are categorized as symptoms (as is done with quantitative symptom measures), the 
mere process of categorization may result in interoceptive bias, making the patient more likely to 
interpret something as a symptom.73 While quantitative methodologies certainly are appropriate, it 
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is important to recognize the weaknesses of quantitative methods in relation to symptom cluster 
research, and to augment quantitative methods and advance symptom science through the use 
of qualitative and mixed-methods approaches. 
Hospitalizations and ED visits for AF are on the rise,74 costly,74 and negatively impact 
quality of life.75,76 The findings from these studies will be useful for designing interventions aimed 
at safely reducing healthcare utilization among individuals with AF. Appropriate interventions 
include those aimed at improving self-care. Symptom perception is a vital component of self-care 
due to its influence on decisions to seek care.7 Knowledge deficits regarding appropriate self-care 
for AF have been documented77-81 and addressed10,82,83 in a limited number of studies to date. 
While knowledge is an important contributor to self-care, knowledge alone is insufficient to ensure 
an appropriate response to symptoms, and as such self-care interventions should aim to also 
improve skills, confidence, compatibility with patient values, and accurate symptom 
interpretation.7 Nurse-led AF programs in Australia and the Netherlands that included self-care 
elements and were designed to engage patients and improve knowledge have been successful at 
reducing hospitalizations and prolonging survival.10,83 The body of work reported here improves 
our ability to build on and replicate these studies with interventions targeted to those patients who 
are at the most risk. 
Implications for Clinical Practice 
 Patients with AF are often symptomatic and symptoms are typically treated with a 
medical and/or procedural rate and/or rhythm control strategy. These studies revealed one 
modifiable clinical characteristic, BMI, which is associated with more severe symptom clusters. In 
line with other recent research,43-45 this finding supports that weight reduction and exercise could 
be appropriate strategies to employ clinically as an approach to AF symptom management.  
 Most importantly, this work identifies specific clusters of patients most at risk for ED visits 
and hospitalizations based on symptoms, demographic, and clinical variables. These results 
should be used clinically as an additional form of risk stratification. While education is generally 
provided for all patients, it is often rushed, or assumed to have been covered at previous 
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appointments. These higher risk patients should be provided adequate time for education (and re-
education) at follow up appointments. Topics covered should include concerning signs or 
symptoms to report, the importance of medication adherence and reasons for each medication, 
signs and symptoms to monitor in relation to comorbid heart failure, and the warnings signs of 
stroke. Additionally, these patients may benefit from telephone based follow up with a nurse or 
nurse practitioner, at least until their heart rate and other treatment parameters are stabilized.  
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